BRPI1009936A2 - method of promoting the exacerbated increase in plant biomass - Google Patents
method of promoting the exacerbated increase in plant biomass Download PDFInfo
- Publication number
- BRPI1009936A2 BRPI1009936A2 BRPI1009936-0A BRPI1009936A BRPI1009936A2 BR PI1009936 A2 BRPI1009936 A2 BR PI1009936A2 BR PI1009936 A BRPI1009936 A BR PI1009936A BR PI1009936 A2 BRPI1009936 A2 BR PI1009936A2
- Authority
- BR
- Brazil
- Prior art keywords
- seq
- plant
- belonging
- sequence
- vector
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 43
- 230000001737 promoting effect Effects 0.000 claims abstract description 20
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 12
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 12
- 239000002157 polynucleotide Substances 0.000 claims abstract description 12
- 235000013311 vegetables Nutrition 0.000 claims abstract description 12
- 230000031016 anaphase Effects 0.000 claims abstract description 11
- 239000002028 Biomass Substances 0.000 claims abstract description 10
- 241000196324 Embryophyta Species 0.000 claims description 80
- 239000013598 vector Substances 0.000 claims description 44
- 244000061176 Nicotiana tabacum Species 0.000 claims description 19
- 230000009466 transformation Effects 0.000 claims description 19
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 17
- 239000013612 plasmid Substances 0.000 claims description 14
- 230000012010 growth Effects 0.000 claims description 13
- 230000002018 overexpression Effects 0.000 claims description 13
- 238000010367 cloning Methods 0.000 claims description 12
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 11
- 239000002299 complementary DNA Substances 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 10
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 9
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 7
- 240000003768 Solanum lycopersicum Species 0.000 claims description 7
- 238000010804 cDNA synthesis Methods 0.000 claims description 6
- 244000017020 Ipomoea batatas Species 0.000 claims description 5
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 5
- 241001233957 eudicotyledons Species 0.000 claims description 5
- 210000001938 protoplast Anatomy 0.000 claims description 5
- 244000075850 Avena orientalis Species 0.000 claims description 4
- 235000007319 Avena orientalis Nutrition 0.000 claims description 4
- 244000004281 Eucalyptus maculata Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 240000003183 Manihot esculenta Species 0.000 claims description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007238 Secale cereale Nutrition 0.000 claims description 4
- 244000082988 Secale cereale Species 0.000 claims description 4
- 240000006394 Sorghum bicolor Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 230000001052 transient effect Effects 0.000 claims description 3
- 241000209510 Liliopsida Species 0.000 claims description 2
- 230000021615 conjugation Effects 0.000 claims description 2
- 230000035772 mutation Effects 0.000 claims description 2
- 235000012015 potatoes Nutrition 0.000 claims description 2
- 238000009713 electroplating Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 37
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 108091034117 Oligonucleotide Proteins 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
- 230000006798 recombination Effects 0.000 description 11
- 238000005215 recombination Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 102000052584 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Human genes 0.000 description 9
- 101000693970 Homo sapiens Scavenger receptor class A member 3 Proteins 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 230000008635 plant growth Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000010455 vermiculite Substances 0.000 description 5
- 235000019354 vermiculite Nutrition 0.000 description 5
- 229910052902 vermiculite Inorganic materials 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 102100036289 Calcium-binding mitochondrial carrier protein SCaMC-2 Human genes 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 238000002123 RNA extraction Methods 0.000 description 4
- 108091006455 SLC25A25 Proteins 0.000 description 4
- 102000044159 Ubiquitin Human genes 0.000 description 4
- 108090000848 Ubiquitin Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000010165 autogamy Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108700001666 APC Genes Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 238000007400 DNA extraction Methods 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 2
- 241000589159 Agrobacterium sp. Species 0.000 description 2
- 102000052591 Anaphase-Promoting Complex-Cyclosome Apc6 Subunit Human genes 0.000 description 2
- 102000052583 Anaphase-Promoting Complex-Cyclosome Apc8 Subunit Human genes 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 101000884308 Dictyostelium discoideum Anaphase-promoting complex subunit 6 Proteins 0.000 description 2
- 101000912119 Dictyostelium discoideum Anaphase-promoting complex subunit 8 Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000012901 Milli-Q water Substances 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 239000002551 biofuel Substances 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229960004261 cefotaxime Drugs 0.000 description 2
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 101150082072 14 gene Proteins 0.000 description 1
- 101710088758 23kDa protein Proteins 0.000 description 1
- 101150060590 ANAPC5 gene Proteins 0.000 description 1
- 101150022917 ARGOS gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 102000052594 Anaphase-Promoting Complex-Cyclosome Apc2 Subunit Human genes 0.000 description 1
- 102000052589 Anaphase-Promoting Complex-Cyclosome Apc4 Subunit Human genes 0.000 description 1
- 102000052588 Anaphase-Promoting Complex-Cyclosome Apc5 Subunit Human genes 0.000 description 1
- 108700004604 Anaphase-Promoting Complex-Cyclosome Apc5 Subunit Proteins 0.000 description 1
- 101100162893 Arabidopsis thaliana APC7 gene Proteins 0.000 description 1
- 102100036290 Calcium-binding mitochondrial carrier protein SCaMC-1 Human genes 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 101150023302 Cdc20 gene Proteins 0.000 description 1
- 102000038594 Cdh1/Fizzy-related Human genes 0.000 description 1
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 101000869747 Homo sapiens Mitochondrial carrier protein SCaMC-3L Proteins 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 101150023114 RNA1 gene Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108091006464 SLC25A23 Proteins 0.000 description 1
- 108091006463 SLC25A24 Proteins 0.000 description 1
- 238000010818 SYBR green PCR Master Mix Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 101150082657 apc5 gene Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 101150102092 ccdB gene Proteins 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 101150070926 ct gene Proteins 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008636 plant growth process Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000012755 real-time RT-PCR analysis Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
MéTODO DE PROMOçãO DO AUMENTO EXACERBADO DA BIOMASSA VEGETAL. A invenção refere-se a um método de promoção do aumento exacerbado da biomassa vegetal, na ordem de 30 a 80% superior ao das plantas não transformadas, pela introdução de uma sequência polinucleotidica no genoma de um vegetal de interesse comercial. A sequência identificadora 1 (Seq.ld1) ou a sequência identificadora 2 (Seq.ld 2) codificam um gene pertencente ao complexo promotor da anáfase/ciclossoma (APC/C), podendo ser a bem como sequências homólogas, ortologas ou parálogas.METHOD OF PROMOTING THE EXACERATED RISE OF VEGETABLE BIOMASS. The invention relates to a method of promoting an exacerbated increase in plant biomass by 30 to 80% greater than unprocessed plants by introducing a polynucleotide sequence into the genome of a plant of commercial interest. The identifying sequence 1 (Seq.ld1) or the identifying sequence 2 (Seq.ld 2) encodes a gene belonging to the anaphase / cyclosome promoter complex (APC / C), and may be as well as homologous, orthologous or paralogous sequences.
Description
MÉTODO DE PROMOÇÃO DO AUMENTO EXACERBADO DA BIOMASSA VEGETALMETHOD FOR PROMOTION OF EXACERATED VEGETABLE BIOMASS INCREASE
ANTECEDENTES DA INVENÇÃOBACKGROUND OF THE INVENTION
Aumento da produtividade agrícola, tanto para a indústria de alimentos quanto para a indústria de produção de biocombustíveis poderia resolver o problema da falta de alimento no mundo, amparando assim nossa crescente população. Resolver os problemas que enfrentamos e que ainda iremos enfrentar por muito tempo, devido a nossa principal fonte de energia (combustível), o petróleo, não ser renovável, assim com a diminuição da poluição no mundo, visto que estamos falando no aumento na produção de biocombustíveis.Increasing agricultural productivity for both the food industry and the biofuel industry could solve the world's food shortage, thus supporting our growing population. Solve the problems we face and will still face for a long time, because our main source of energy (fuel), oil, is not renewable, as well as the decrease in pollution in the world, as we are talking about the increase in the production of biofuels.
Nas últimas décadas, vem aumentando o número de pesquisas que visam à obtenção de plantas geneticamente modificadas que apresentem um crescimento mais vigoroso que o normalmente verificado na natureza.In the last decades, the number of researches that aim to obtain genetically modified plants that present a more vigorous growth than that normally verified in the nature has been increasing.
A empresa belga CROPDESIGN é líder nessa linha de pesquisas, sendo detentora de diversos pedidos de patente sobre este tema, incluindo os pedidos de patente PI0513352-1, PI0514478, PI0317754, W005059147, W005117568 e W006005751.The Belgian company CROPDESIGN is a leader in this line of research and holds several patent applications on this subject, including patent applications PI0513352-1, PI0514478, PI0317754, W005059147, W005117568 and W006005751.
O PI0513352-1 descreve um método para melhorar características de crescimento de plantas aumentando-se expressão e/ou atividade em uma planta, de uma quinase receptora de LRR ou um homólogo desta. Este método compreende introduzir, em uma planta mono ou dicotiledônea, uma molécula de ácido nucléico RLK827 ou variante funcional desta.PI0513352-1 describes a method for enhancing plant growth characteristics by increasing expression and / or activity in a plant, an LRR receptor kinase or a homolog thereof. This method comprises introducing into a mono or dicotyledonous plant an RLK827 nucleic acid molecule or functional variant thereof.
O PI0514478-7 refere-se a um método de promoção do crescimento de um vegetal pela introdução na planta do gene codificante de uma proteína ligante do RNA que compreenda 2 ou 3 motifis de reconhecimento RNA, contendo as seqüências polipeptídicas KIFVGGL e RPRGFGF.PI0514478-7 relates to a method of promoting plant growth by introducing into the plant the coding gene for an RNA ligand protein comprising 2 or 3 RNA recognition motifs containing the KIFVGGL and RPRGFGF polypeptide sequences.
Já o PI0317754-8 se relaciona a um método de promoção do crescimento de um vegetal pela modificação da expressão da proteína zinc finger 2xC2H2 em plantas de interesse comercial.PI0317754-8 relates to a method of promoting plant growth by modifying the expression of zinc finger 2xC2H2 protein in plants of commercial interest.
Em relação aos pedidos de patente PCT citados, vemos que o documento W005059147 descreve um método de promoção do crescimento vegetal pelo aumento da expressão do gene codificante da proteína GRUBX. O documento W005117568 descreve plantas com crescimento aumentado e método de obtenção das mesmas, pela inserção do gene codificante da proteína E2F dimeriztion partner (DP) no genoma vegetal. Já o pedido W006005751 refere-se a um método de promoção do crescimento vegetal pelo aumento da atividade do polipeptídio YIPPEE-like ou seu homologo em vegetais de interesse.Referring to the PCT patent applications cited, we see that document W005059147 describes a method of promoting plant growth by increasing expression of the GRUBX protein coding gene. W005117568 describes plants with increased growth and method of obtaining them by inserting the gene encoding the protein E2F dimeriztion partner (DP) into the plant genome. The W006005751 application refers to a method of promoting plant growth by increasing the activity of the YIPPEE-like polypeptide or its homologous in plants of interest.
A patente americana US6897359 (Senesco, Inc) protege um método de promoção do crescimento do tomate pela inserção do gene da desoxihipusina sintetase no genoma do tomateiro, que também é capaz de tornar o tomate mais resistente a pragas.US6897359 (Senesco, Inc) protects a method of promoting tomato growth by inserting the deoxyhypine synthase gene into the tomato genome, which is also capable of making the tomato more pest resistant.
O documento W007115064 (PIONEER HI-BRED INT.) descreve um método de modulação do tamanho de um vegetal, pela expressão no dito vegetal do gene ARGOS ou seus homólogos.W007115064 (PIONEER HI-BRED INT.) Describes a method of modulating the size of a plant by expression in said plant of the ARGOS gene or homologues thereof.
Todos estes documentos de patente são capazes de promover um pequeno, ou moderado aumento no tamanho do vegetal, sendo que alguns destes documentos são efetivos somente em órgãos específicos da planta, não sendo efetivos na promoção do crescimento do vegetal como um todo.All of these patent documents are capable of promoting a small or moderate increase in plant size, and some of these documents are effective only in specific plant organs and are not effective in promoting plant growth as a whole.
O complexo formador da Anáfase (APC ou ciclossomo), é o principal ligador de ubiquitina necessário para o início da anáfase, atuando no check- point existente entre o fim da metáfase e o inicio da anáfase. O ciclossomo promove a ubiquitinação de proteínas como ciclinas e securinas, promovendo sua degradação pelo proteassoma 26S, tanto na mitose como na meiose.Anaphase-forming complex (APC or cyclosome) is the main ubiquitin linker necessary for the onset of anaphase, acting at the checkpoint between the end of metaphase and the beginning of anaphase. The cyclosome promotes the ubiquitination of proteins such as cyclins and securins, promoting their degradation by the 26S proteasome, both in mitosis and meiosis.
Este complexo é regulado pela sua fosforilação, assim como, por diversos outros ativadores e inibidores que alteram sua especificidade pelo substrato em diferentes fases do ciclo celular. Este "controle fino" garante a degradação no tempo correto dos reguladores do ciclo celular.This complex is regulated by its phosphorylation, as well as by several other activators and inhibitors that alter its substrate specificity at different stages of the cell cycle. This "fine control" ensures timely degradation of cell cycle regulators.
Dentre os diversos componentes do ciclossomo, temos as proteínas APC1, APC2, APC3, APC4, APC5, APC6, APC7, APC8 e outros. Dentre estas proteínas, vemos que APC3, APC6, APC7 e APC8 possuem diversas repetições tetratricopeptídicas (TPR) que são motifs de interação proteína- proteína. Kraft et al (2003) demonstraram in vitro que APC3 e APC7 interagem com os motifs IR da Cdc20 e Cdh1. Além disso, APC3 e APC7 possuem 4 subunidades TRP que são responsáveis pela maior parte dos sítios de fosforilação presentes no complexo APC/ciclossomo.Among the various components of the cyclosome, we have the proteins APC1, APC2, APC3, APC4, APC5, APC6, APC7, APC8 and others. Among these proteins, we see that APC3, APC6, APC7 and APC8 have several tetratricopeptide repeats (TPR) which are motifs of protein-protein interaction. Kraft et al (2003) demonstrated in vitro that APC3 and APC7 interact with the Cdc20 and Cdh1 IR motifs. In addition, APC3 and APC7 have 4 TRP subunits that account for most of the phosphorylation sites present in the APC / cyclosome complex.
O APC7 é um gene do Complexo Promotor da Anáfase, ele já foi descrito em vertebrados e em plantas, mas não foi identificado em leveduras.APC7 is an Anaphase Promoter Complex gene, it has been described in vertebrates and plants, but has not been identified in yeast.
Este gene foi primeiramente incorretamente anotado quando o genoma de A. thaliana foi seqüenciado (The Arabidopsis Genome Initiative1 2000) e apenas a região C-terminal com a proteína NR-Iike foi identificada. Mais tarde, ele foi seqüenciado e corretamente anotado conforme seqüência depositada no TAIR (www.arabidopsis.org) pelo numero de acesso At2g39090.This gene was first incorrectly noted when the A. thaliana genome was sequenced (The Arabidopsis Genome Initiative1 2000) and only the C-terminal region with the NR-Iike protein was identified. It was later sequenced and correctly annotated as filed in the TAIR (www.arabidopsis.org) by access number At2g39090.
O tabaco possui um gene, que codifica uma proteína de 23 kDa com atividade anti-viral chamada "inhibitor of virus replication" (inibidor de replicação viral) (WfR)-like. Este gene possui alta homologia com a região C-terminal de um dos componentes do complexo formador de anáfase (APC ou ciclossomo), o APC7. O ciclossomo é um complexo de proteínas ativados durante a mitose, desencadeando o inicio da anáfase. O ciclossomo é uma proteína do tipo E3 ubiquitina ligase que tem a função de marca as proteínas alvo de degradação pelo proteassoma 26S.Tobacco has a gene, which encodes a 23 kDa protein with anti-viral activity called an inhibitor of virus replication (WfR) -like. This gene has high homology to the C-terminal region of one of the components of the anaphase-forming complex (APC or cyclosome), APC7. The cyclosome is a complex of proteins activated during mitosis, triggering the onset of anaphase. Cyclosome is an E3 ubiquitin ligase type protein that has the function of labeling proteins targeting degradation by 26S proteasome.
A (NR)-like foi primeiramente encontrada no meio de cultura de protoplastos derivados de Nicotiana tabacum cv. Samsun NN (protoplastos- IVR) infectados com Tabacco mosaic virus (TMV) e esta proteína reduz poderosamente a replicação do TMV em ensaios com N. tabacum (AKAD et ai, 2005).(NR) -like was first found in the culture medium of Nicotiana tabacum cv. Samsun NN (IVR protoplasts) infected with Tabacco mosaic virus (TMV) and this protein powerfully reduces TMV replication in assays with N. tabacum (AKAD et al, 2005).
Recentemente, em um trabalho apresentado por Park et ai (2005), foi demonstrado que alguns tipos de câncer de mama estão envolvidos com a perda de expressão do APC7, sendo que esta é mais comum em casos de carcinoma de mama com parâmetros prognóstico pior ou características malignas. Eles sugerem então que a desregulação da atividade do APC, possivelmente por baixa expressão do APC7, pode estar associada com tumorigênese em câncer de mama.Recently, in a paper presented by Park et al (2005), it has been shown that some types of breast cancer are involved with loss of expression of APC7, which is more common in cases of breast carcinoma with worse prognostic parameters or malignant features. They then suggest that dysregulation of APC activity, possibly due to low APC7 expression, may be associated with tumorigenesis in breast cancer.
A invenção que será aqui descrita, é capaz de promover um crescimento exacerbado do vegetal como um todo, sendo visíveis seus efeitos em órgãos como folha, caule e raiz. DESCRIÇÃO DAS FIGURASThe invention which will be described herein is capable of promoting an exaggerated growth of the vegetable as a whole, being visible its effects on organs such as leaf, stem and root. DESCRIPTION OF THE FIGURES
Figura 1: Esquema de multiplicação das plantas transformadas. As plantas transformadas (T0) geraram sementes por autofecundação. A segregação dessas sementes foi determinada (3:1) e as plantas passadas para a terra (geração T1). As plantas da geração T1 geraram sementes por autofecundação (geração T2). Plantas homozigotas e hemizigotas de cada linhagem foram objetos das análises.Figure 1: Scheme of multiplication of transformed plants. The transformed plants (T0) generated seeds by self-fertilization. The segregation of these seeds was determined (3: 1) and the plants passed to the earth (generation T1). The T1 generation plants generated seeds by self-fertilization (T2 generation). Homozygous and hemizygote plants of each strain were analyzed.
Figura 2: Comparação do crescimento exacerbado plantas transformadas e plantas controle. Peso = média entre 5 plantas de cada tipo.Figure 2: Comparison of exacerbated growth of transformed plants and control plants. Weight = average of 5 plants of each type.
Figura 3: Comparação do número de frutos na porção terminal dos ramos encontrados nas plantas transformadas e plantas controle.Figure 3: Comparison of the number of fruits in the terminal portion of the branches found in transformed and control plants.
Figura 4: Comparação da largura das folhas encontrada nas plantas transformadas e plantas controle.Figure 4: Comparison of leaf width found in transformed and control plants.
Figura 5: Comparação da área das folhas encontradas em plantas transformadas e plantas controle.Figure 5: Comparison of leaf area found in transformed plants and control plants.
SUMÁRIO DA INVENÇÃOSUMMARY OF THE INVENTION
Um dos objetos desta invenção trata-se de um método de transformação de promoção do crescimento exacerbado de um vegetal pela introdução e superexpressão no genoma deste vegetal de uma seqüência polinucleotídica (Seq. Id 1 e/ou Seq. Id 2) referente a um gene pertencente ao complexo promotor na anáfase/ciclossomo (APC/C).One of the objects of this invention is a transformation method of promoting the exacerbated growth of a plant by introducing and overexpressing a plant polynucleotide sequence (Seq. Id 1 and / or Seq. Id 2) into a plant's genome. belonging to the anaphase / cyclosome promoter complex (APC / C).
DESCRIÇÃO DETALHADA DA INVENÇÃODETAILED DESCRIPTION OF THE INVENTION
A invenção refere-se ao método de promoção do aumento exacerbado da biomassa vegetal que compreende a introdução de uma seqüência polinucleotídica no genoma de um vegetai de interesse comercial. A dita seqüência polinucleotídica a ser inserida no genoma de um vegetal de interesse comercial, deve estar ligada a um vetor de super-expressão e deve ser uma seqüência polinucleotídica que codifica um gene pertencente ao complexo promotor da anáfase e/ou uma seqüência quimérica contendo um gene pertencente ao complexo promotor da anáfase e uma seqüência de T- DNA promotora de uma mutação insercional dirigida, podendo, preferencialmente ser inserida a seqüência identificadora 1 (Seq.ldl) e/ou a seqüência identificadora 2 (Seq.Id 2) bem como suas seqüências homólogas, ortologas ou parálogas. Para esta invenção temos que seqüências homólogas são aquelas seqüências que codificam proteínas, enzimas, peptídeos ou oligopeptídeos contendo substituições, deleções e/ou inserções na seqüência de aminoácidos, mas que mantêm sua atividade biológica e/ou funcional semelhantes à da proteína inalterada. Seqüências parálogas são seqüências de uma mesma espécie que derivam da duplicação de uma seqüência polinucleotídica ancestral; e, seqüências ortologas são seqüências polinucleotídicas encontradas em espécies diferentes, tendo sido originadas em um processo de especiação a partir de uma seqüência polinucleotídica ancestral.The invention relates to the method of promoting exacerbated increase in plant biomass comprising introducing a polynucleotide sequence into the genome of a plant of commercial interest. Said polynucleotide sequence to be inserted into the genome of a plant of commercial interest must be linked to an overexpression vector and must be a polynucleotide sequence encoding a gene belonging to the anaphase promoter complex and / or a chimeric sequence containing a gene belonging to the anaphase promoter complex and a T-DNA sequence promoter of a directed insertional mutation, preferably the identifier sequence 1 (Seq.ldl) and / or the identifier sequence 2 (Seq.Id 2) may be inserted as well as their homologous, ortholog or paralog sequences. For this invention we have that homologous sequences are those sequences that encode proteins, enzymes, peptides or oligopeptides containing amino acid sequence substitutions, deletions and / or insertions, but which maintain their biological and / or functional activity similar to that of the unchanged protein. Paralogous sequences are sequences of the same species that derive from the duplication of an ancestral polynucleotide sequence; and, ortholog sequences are polynucleotide sequences found in different species, having originated in a speciation process from an ancestral polynucleotide sequence.
Preferencialmente, as ditas seqüências homólogas, parálogas e ortólogas apresentam uma identidade a nível protéico entre 50 a 95% quando comparadas, de forma alinhada ou não, em ferramentas de comparação genômicas usuais, como por exemplo, mas não limitado aos programas BLASTp, Clustal e COBALT. Mais preferivelmente, a identidade a nível protéico das seqüências homólogas, parálogas e ortólogas deve estar compreendida entre 75 a 90% quando comparada às seqüências identificadoras 1 e/ou 2.Preferably, said homologous, paralogous and orthologous sequences have a protein-level identity of between 50 and 95% when compared, aligned or not, to standard genomic comparison tools, for example, but not limited to BLASTp, Clustal and COBALT More preferably, the protein-level identity of homologous, paralogous and orthologous sequences should be between 75 and 90% when compared to identifier sequences 1 and / or 2.
Entende-se por vegetais de interesse comercial, os vegetais pertencentes às famílias monocotiledôneas, dicotiledôneas e eudicotiledôneas tradicionalmente empregados pelos seres humanos na agricultura de larga escala, como por exemplo, os vegetais pertencentes ao grupo consistido de: milho, cana-de-açúcar, sorgo, soja, feijão, tomate, tabaco, batata inglesa, batata-doce, arroz, eucalipto, mandioca, aveia e centeio, mas não limitado a estas espécies.Vegetables of commercial interest are vegetables of the monocotyledonous, dicotyledonous and eudicotyledonous families traditionally employed by humans in large-scale agriculture, such as vegetables in the group consisting of: maize, sugar cane, sorghum, soybeans, beans, tomatoes, tobacco, potatoes, sweet potatoes, rice, eucalyptus, cassava, oats and rye, but not limited to these species.
O método desta invenção é obtido, pela construção em um vetor de expressão, preferencialmente um plasmídeo de superexpressão, onde obrigatoriamente deve ser inserida uma seqüência polinucleotídica de interesse, podendo ser empregada a Seq.Id 1 ou Seq.Id 2, que serão superexpressadas pelo vegetal após sua inserção no genoma do mesmo.The method of this invention is obtained by constructing an expression vector, preferably an overexpression plasmid, where a polynucleotide sequence of interest must be inserted, which may be employed as Seq.Id 1 or Seq.Id 2, which will be overexpressed by after its insertion in the genome.
Para esta invenção, temos que vetor de superexpressão é aquele que contém uma seqüência promotora forte e genes seletivos. A seqüência promotora desta invenção pode ser a seqüência de um promotor constitutivo, específica ou indutível. Preferencialmente, o vetor de superexpressão é um plasmídio adequado para a transformação vegetal e a seqüência promotora empregada é uma seqüência promotora constitutiva forte, podendo ser qualquer uma pertencente ao grupo consistido de: promotor nos, promotor 35S, promotor MPNPR1, promotor ubiquitina I e/ou o promotor 19S; e os genes seletivos são genes que conferem resistência a antibióticos e/ou genes ligados ao metabolismo da β-galactosidase. Mais preferencialmente ainda, os vetores empregados neste processo são os plasmídeos pk7WG2( pk7WGF2 e/ou pk7WG43DNew.For this invention, we have that overexpression vector is one that contains a strong promoter sequence and selective genes. The promoter sequence of this invention may be the sequence of a specific or inducible constitutive promoter. Preferably, the overexpression vector is a suitable plasmid for plant transformation and the promoter sequence employed is a strong constitutive promoter sequence, which may be any of the group consisting of: nos promoter, 35S promoter, MPNPR1 promoter, ubiquitin I promoter, and / or the 19S promoter; and selective genes are genes that confer resistance to antibiotics and / or genes linked to β-galactosidase metabolism. Even more preferably, the vectors employed in this process are plasmids pk7WG2 (pk7WGF2 and / or pk7WG43DNew.
Diversas técnicas de biologia molecular conhecidas por aqueles versados na técnica podem ser empregadas para se obter a inserção das seqüências nucleotídicas desejadas no vetor de superexpressão, como por exemplo, as técnicas possibilitam a execução das seguintes etapas do processo de clonagem de vetores: isolamento do RNA total de um vegetal superior; seleção da fração de RNA poli (A)+; síntese de cDNA (RT-PCR, RT- PCR em tempo real, RT-PCR quantitativo em tempo real); clonagem da seqüência em vetor transiente; clonagem da seqüência em vetor estável específico. Preferencialmente o vegetal superior empregado no isolamento do RNA total pertence a espécie Arabidopsis thaliana.Several molecular biology techniques known to those skilled in the art may be employed to obtain the desired nucleotide sequences into the overexpression vector, for example, the techniques enable the following steps of the vector cloning process to be performed: RNA isolation total of a superior vegetable; selection of poly (A) + RNA fraction; cDNA synthesis (RT-PCR, real-time RT-PCR, quantitative real-time RT-PCR); cloning of transient vector sequence; specific stable vector sequence cloning. Preferably the higher plant employed in total RNA isolation belongs to Arabidopsis thaliana species.
Para que a síntese do cDNA seja possível, devem ser empregadas como iniciadores da amplificação as seqüências identificadoras 3 a 7. De acordo com a seqüência a ser amplificada e posteriormente inserida no vetor de superexpressão, empregam-se duas dentre as iniciadoras listadas. Os exemplos darão maior clareza sobre esta etapa, deste objeto da patente.For cDNA synthesis to be possible, the identification sequences 3 to 7 should be used as amplification initiators. According to the sequence to be amplified and later inserted into the overexpression vector, two of the listed primers are used. The examples will provide more clarity on this step of this patent object.
Após a inserção da seqüência polinucleotídica desejada no vetor de expressão, deve ser realizada em ordem, as seguintes etapas: transformação de um hospedeiro transiente (de manutenção) para facilitar a seleção e multiplicação dos clones; transformação no hospedeiro definitivo, transformação vegetal e regeneração do vegetal transformado.After insertion of the desired polynucleotide sequence into the expression vector, the following steps should be performed in order: transformation of a transient (maintenance) host to facilitate selection and multiplication of clones; definitive host transformation, plant transformation and regeneration of the transformed plant.
Podem ser empregadas quaisquer técnicas diretas ou indiretas de transformação vegetal pertencentes ao estado da técnica, tais como as técnicas de transformação pertencentes ao grupo consistido de: conjugação com Agrobacterium tumefaciens, biobalística, eletroporação de protoplastos, "floral dip" e transformação de protoplastos com policátions.Any direct or indirect plant transformation techniques pertaining to the state of the art may be employed, such as transformation techniques belonging to the group consisting of: Agrobacterium tumefaciens conjugation, biobalistics, protoplast electroporation, floral dip and polycation protoplast transformation .
As seqüências empregadas neste processo de promoção do crescimento exacerbado de um vegetal são seqüências pertencentes ao complexo APC/C e/ou seqüências quiméricas contendo uma seqüência mutacional dirigida inserida em uma seqüência pertencente ao complexo APC/C. A seqüência identificadora 1 (Seq.Id. 1) é referente a seqüência completa de um gene pertencente ao complexo formador de anáfase (genes APC). O gene codificado pela Seq.Id. 1 sofre um processamento alternativo (splicing) que gera a seqüência identificadora 2 (Seq.Id. 2) que contem uma elevada homologia ao gene (IVR)-like originalmente isolado do tabaco. Os genes APC são descritos como tendo a função de regular o processo de divisão celular. Já foi demonstrado também que a diminuição ou perda da expressão do APC7 está envolvida no carcinoma de mama. Não existe, entretanto, nenhuma descrição anterior descrevendo que a superexpressão em vegetais, de genes APC desencadeia o processo de crescimento vegetal exacerbado, como empregado por este pedido de patente.The sequences employed in this process of promoting plant overgrowth are sequences belonging to the APC / C complex and / or chimeric sequences containing a directed mutational sequence inserted into a sequence belonging to the APC / C complex. The identifying sequence 1 (Seq.Id. 1) refers to the complete sequence of a gene belonging to the anaphase forming complex (APC genes). The gene encoded by Seq.Id. 1 undergoes an alternative splicing that generates the identifier sequence 2 (Seq.Id. 2) which contains a high homology to the originally isolated tobacco-like gene (IVR). APC genes are described as having the function of regulating the process of cell division. It has also been shown that decreased or lost APC7 expression is involved in breast carcinoma. There is, however, no prior description describing that overexpression of APC genes in plants triggers the exacerbated plant growth process as employed by this patent application.
As plantas transformadas de acordo com este processo apresentam um crescimento exageradamente maior, quando comparadas às plantas controle (plantas não transformadas), crescimento esse tanto relacionado ao tamanho foliar e porte planta quanto principalmente no que se diz respeito à biomassa vegetal. Notadamente, o crescimento da biomassa apresentado pelas plantas transformadas é entre 30 a 80% superior ao das plantas não transformadas. Preferivelmente, o crescimento das plantas transformadas pelo processo descrito é entre 40 a 65% superior ao das plantas não transformadas.The plants transformed according to this process have an exaggerated growth, when compared to the control plants (unprocessed plants), growth related to the leaf size and plant size and mainly to the plant biomass. Notably, the biomass growth presented by the transformed plants is between 30 and 80% higher than the unprocessed ones. Preferably, the growth of plants transformed by the process described is 40 to 65% higher than that of unprocessed plants.
Portanto, este objeto da invenção deve ser empregado na promoção do crescimento exacerbado de vegetais de interesse comercial, pertencentes às famílias monocotiledôneas, dicotiledôneas e eudicotiledôneas pertencentes ao grupo consistido de: milho, cana-de-açúcar, sorgo, soja, feijão, tomate, tabaco, batata inglesa, batata-doce, arroz, eucalipto, mandioca, aveia e centeio, mas não limitado a estas espécies.Therefore, this object of the invention should be employed in promoting the overgrowth of commercially important vegetables belonging to the monocotyledonous, dicotyledonous and eudicotyledonous families belonging to the group consisting of: corn, sugarcane, sorghum, soybeans, beans, tomatoes, tobacco, sweet potatoes, sweet potatoes, rice, eucalyptus, cassava, oats and rye, but not limited to these species.
Esta invenção ainda trata de um vetor de superexpressão, apropriado para a transformação de um vegetal pertencente às famílias monocotiledôneas, dicotiledôneas e eudicotiledôneas, contendo qualquer uma das seqüências identificadoras 1 e/ou 2 além de uma seqüência promotora forte e genes seletivos. A seqüência promotora desta invenção pode ser a seqüência de um promotor constitutivo, específica ou indutível.This invention further relates to an overexpression vector suitable for transformation of a plant belonging to the monocotyledon, dicotyledon and eudicotyledon families, containing any of the identifying sequences 1 and / or 2 in addition to a strong promoter sequence and selective genes. The promoter sequence of this invention may be the sequence of a specific or inducible constitutive promoter.
Preferencialmente, a seqüência promotora empregada é uma seqüência promotora constitutiva forte, podendo ser qualquer uma pertencente ao grupo consistido de: promotor nos, promotor 35S, promotor MPNPR1, promotor ubiquitina I e/ou o promotor 19S. Airida preferencialmente, genes seletivos são aqueles que conferem resistência a antibióticos e/ou genes ligados ao metabolismo da β-galactosidase. Mais preferencialmente ainda, os vetores empregados neste processo são os plasmídeos pk7WG2,0 e pk7WG43DNew.Preferably, the promoter sequence employed is a strong constitutive promoter sequence, any one of which may be from the group consisting of: nos promoter, 35S promoter, MPNPR1 promoter, ubiquitin I promoter, and / or the 19S promoter. Preferably, airida, selective genes are those that confer resistance to antibiotics and / or genes linked to β-galactosidase metabolism. Most preferably, the vectors employed in this process are plasmids pk7WG2,0 and pk7WG43DNew.
Os exemplos que serão dados a seguir são meramente ilustrativos, tendo o intuito tão somente de comprovar as concretizações realizadas pelos inventores. Estes exemplos não devem ser empregados na delimitação dos direitos do depositante.The following examples are for illustrative purposes only and are intended to prove the embodiments of the inventors. These examples should not be used in delimiting the depositor's rights.
Exemplo 1: Cultivo vegetal in vitro.Example 1: Plant culture in vitro.
Exemplo 1.1: Cultivo de Arabidopsis thaliana.Example 1.1: Cultivation of Arabidopsis thaliana.
Plantas de Arabidopsis thaliana ecotipo Columbia foram crescidas em potes contendo terra autoclavada e vermiculita (2:1) ou em meio GM contendo sais MS (Murashige e Skoog, 1962). Para a esterilização, as sementes de Arabidopsis, mantidas a 4°C, foram colocadas em tubos de microcentrífuga contendo 1 mL de etanol a 70 % por dois minutos. Após a retirada do etanol, as sementes foram colocadas em uma solução de hipoclorito de sódio a 5% e Tween 20 a 0,05% por 10 minutos. As mesmas foram lavadas cinco vezes em água destilada autoclavada. As sementes esterilizadas foram dispostas em meio de cultura sólido com o auxílio de palito de dentes autoclavados. A quebra da dormência foi feita a 4°C por pelo menos três dias. As plantas foram cultivadas em casa de vegetação a 21°C com fotoperíodo de 16 horas de luz e 8 horas de escuro.Arabidopsis thaliana ecotype Columbia plants were grown in pots containing autoclaved soil and vermiculite (2: 1) or in GM medium containing MS salts (Murashige and Skoog, 1962). For sterilization, Arabidopsis seeds, kept at 4 ° C, were placed in microcentrifuge tubes containing 1 mL of 70% ethanol for two minutes. After ethanol removal, the seeds were placed in a 5% sodium hypochlorite and 0.05% Tween 20 solution for 10 minutes. They were washed five times in autoclaved distilled water. The sterilized seeds were placed in solid culture medium with the aid of an autoclaved toothpick. Dormancy was broken at 4 ° C for at least three days. The plants were grown in a greenhouse at 21 ° C with photoperiod of 16 hours of light and 8 hours of dark.
Exemplo 1.2: Cultivo de Nicotiana tabacum.Example 1.2: Cultivation of Nicotiana tabacum.
Plantas de Nicotiana tabacum variedade SR1 foram crescidas em vasos contendo terra autoclavada e vermiculita (2:1) ou em placas e potes contendo meio MS. Para a esterilização, as sementes de tabaco, mantidas a 4°C, foram colocadas em tubos de microcentrífuga contendo 1mL de etanol a 70% por dois minutos. Após a retirada do etanol, as sementes foram colocadas em uma solução de hipoclorito de sódio 5% e Tween a 0,01% por 15 minutos. As mesmas foram lavadas cinco vezes em água destilada autoclavada. As sementes esterilizadas foram dispostas em meio de cultura sólido com o auxílio de palitos de madeira autoclavados. As plantas foram cultivadas em casa de vegetação a 28°C com fotoperíodo de 12 horas de luz sob intensidade luminosa entre 3.500-6.000 lux.Nicotiana tabacum variety SR1 plants were grown in pots containing autoclaved soil and vermiculite (2: 1) or in plates and pots containing MS medium. For sterilization, the tobacco seeds, kept at 4 ° C, were placed in microcentrifuge tubes containing 1mL of 70% ethanol for two minutes. After ethanol removal, the seeds were placed in a solution of 5% sodium hypochlorite and 0.01% Tween for 15 minutes. They were washed five times in autoclaved distilled water. The sterilized seeds were placed in solid culture medium with the aid of autoclaved wooden sticks. The plants were grown in a greenhouse at 28 ° C with 12 hours light photoperiod under light intensity between 3,500-6,000 lux.
Exemplo 2: Extração de RNA total e tratamento com DNAse.Example 2: Total RNA extraction and DNAse treatment.
As plantas e órgãos foram coletados após o período de crescimento na terra. O material coletado foi congelado em nitrogênio líquido e mantido a - 70°C. O material foi macerado em nitrogênio líquido e transferido para tubos de microcentrífuga de 1,5mL contendo 500μL de tampão de extração (200mM Tris-Cl pH 7,5; 100mM de LiCI; 5mM EDTA; SDS 1%), 250μL de fenol e 250μL de clorofórmio. A mistura foi agitada por 1 minuto e centrifugada a 20.000xg por minutos a 40°C. A fase aquosa foi transferida para um novo tubo no qual foi adicionado 1 volume de clorofórmio/álcool isoamílico (24:1). A nova mistura foi agitada por 1 minuto e centrifugada a 20.000xg por 15 minutos a 40°C. A fase aquosa foi transferida para um novo tubo, no qual foi adicionado 1 volume de 6M cloreto de lítio. Deixou-se o tubo a 4°C por aproximadamente 16 horas. Posteriormente o material foi centrifugado a 20.000xg por 20 minutos a 40C, o sobrenadante foi descartado e o precipitado foi ressuspenso em 1mL de 3M cloreto de lítio. A mistura foi incubada a - 70°C por 30 minutos e depois centrifugada a 20.000xg por 15 minutos a 40C. O sobrenadante foi descartado e o precipitado lavado com uma solução 70% etanol DEPC. Centrifugou-se a 20.000xg por 5 minutos a 40C. O etanol foi descartado e o RNA precipitado foi ressuspenso em 50μL de água Milli-Q DEPC.Plants and organs were collected after the period of growth in the earth. The collected material was frozen in liquid nitrogen and kept at - 70 ° C. The material was macerated in liquid nitrogen and transferred to 1.5mL microcentrifuge tubes containing 500μL extraction buffer (200mM Tris-Cl pH 7.5; 100mM LiCI; 5mM EDTA; SDS 1%), 250μL phenol and 250μL of chloroform. The mixture was stirred for 1 minute and centrifuged at 20,000xg for minutes at 40 ° C. The aqueous phase was transferred to a new tube in which 1 volume of chloroform / isoamyl alcohol (24: 1) was added. The new mixture was stirred for 1 minute and centrifuged at 20,000xg for 15 minutes at 40 ° C. The aqueous phase was transferred to a new tube to which 1 volume of 6M lithium chloride was added. The tube was left at 4 ° C for approximately 16 hours. Subsequently the material was centrifuged at 20,000xg for 20 minutes at 40 ° C, the supernatant was discarded and the precipitate was resuspended in 1mL of 3M lithium chloride. The mixture was incubated at -70 ° C for 30 minutes and then centrifuged at 20,000xg for 15 minutes at 40 ° C. The supernatant was discarded and the precipitate washed with a 70% DEPC ethanol solution. Centrifuged at 20,000xg for 5 minutes at 40 ° C. Ethanol was discarded and the precipitated RNA was resuspended in 50μL of Milli-Q DEPC water.
Antes da síntese do cDNA, o RNA total foi tratado com DNAse I (Promega), para eliminar qualquer contaminação por DNA genômico. O RNA foi incubado com 0,5U de DNAse por μg de RNA1 no tampão da enzima (200mM de Tris-Cl pH 8,3; 500mM de KCI; 25mM de MgCI2), a 37°C por 10 minutos, depois foi avolumado para 300μ L. O RNA foi purificado pela adição de 1 volume de fenol e centrifugado a 20.000xg por 10 minutos a 40°C. A fase aquosa foi transferida para um novo tubo, no qual foi adicionado 1 volume de clorofórmio. Centrifugou-se a 20.OOOxg por 10 minutos a 40°C e a fase aquosa foi transferida para um novo tubo. O RNA foi precipitado pela adição de 1/10 do volume de 3M acetato de sódio e 2 volumes de etanol absoluto, seguido de incubação a - 70°C por 20 minutos. Posteriormente centrifugou-se a 20.000xg por 20 minutos. O sobrenadante foi descartado e o RNA precipitado foi lavado com uma solução 70% etanol DEPC. Centrifugou-se durante 5 minutos a 20.000xg e o sobrenadante é descartado e o precipitado é ressuspenso em 50μ L de água Milli-Q. Todas as soluções contidas no protocolo de extração de RNA foram tratadas com DEPC 0,1% por 16 horas à temperatura ambiente.Prior to cDNA synthesis, total RNA was treated with DNAse I (Promega) to eliminate any contamination with genomic DNA. The RNA was incubated with 0.5U DNAse per μg RNA1 in enzyme buffer (200mM Tris-Cl pH 8.3; 500mM KCI; 25mM MgCl2) at 37 ° C for 10 minutes, then pelleted. 300μL. RNA was purified by adding 1 volume of phenol and centrifuged at 20,000xg for 10 minutes at 40 ° C. The aqueous phase was transferred to a new tube to which 1 volume of chloroform was added. It was centrifuged at 20,000 xg for 10 minutes at 40 ° C and the aqueous phase was transferred to a new tube. RNA was precipitated by the addition of 1/10 volume of 3M sodium acetate and 2 volumes of absolute ethanol, followed by incubation at -70 ° C for 20 minutes. It was then centrifuged at 20,000xg for 20 minutes. The supernatant was discarded and the precipitated RNA was washed with a 70% ethanol DEPC solution. It is centrifuged for 5 minutes at 20,000xg and the supernatant is discarded and the precipitate is resuspended in 50 µl Milli-Q water. All solutions contained in the RNA extraction protocol were treated with 0.1% DEPC for 16 hours at room temperature.
Após este período, as soluções foram autoclavadas.After this period, the solutions were autoclaved.
Exemplo 3: Síntese de DNA e clonagemExample 3: DNA Synthesis and Cloning
Exemplo 3.1 Síntese da primeira fita de cDNA.Example 3.1 Synthesis of the first cDNA tape.
O RNA total foi tratado com DNAse I e depois foi feita uma reação de transcrição reversa para a obtenção da primeira fita de cDNA a partir do RNAm. As sínteses de primeira fita foram realizadas utilizando 2 kits: "First- Strand cDNA Synthesis Pharmacia Kit" (GE healthcare) e "Taqman First strand cDNA synthesis kit' (Applied Biosystems).Total RNA was treated with DNAse I and then a reverse transcription reaction was performed to obtain the first cDNA strand from mRNA. First strand syntheses were performed using 2 kits: "First-Strand cDNA Synthesis Pharmacia Kit" (GE healthcare) and "Taqman First strand cDNA synthesis kit" (Applied Biosystems).
Exemplo 3.2: clonagens em vetores Gateway.Example 3.2: Cloning on Gateway Vectors.
A primeira fita de cDNA sintetizada usando o "First-Strand cDNA Synthesis Pharmacia Kif foi feita em reações com volume final de 15μL, de acordo com o fabricante. 2μg de RNA total foram desnaturados a 65°C por 10 minutos num volume de 8μL. Após este período de desnaturação foram adicionados ao RNA: 1m L (0,2μg) do oligonucleotídeos Not-dT, 1μL de 200mM DTT e 5μL do "Bulk Mix" (cloned, FPLCpure Murine Reverse Transcriptase, RNAguard, RNAse/DNAse-Free BSA1 dATP, dCTP, dGTP e dTTP). A mistura foi incubada por 1 hora a 37°C. Os cDNAs sintetizados foram tratados com 1U de RNase H por reação.The first cDNA strand synthesized using First-Strand cDNA Synthesis Pharmacia Kif was made in reactions with a final volume of 15μL according to the manufacturer. 2μg of total RNA was denatured at 65 ° C for 10 minutes in a volume of 8μL. After this denaturation period were added to the RNA: 1m L (0.2μg) of Not-dT oligonucleotides, 1μL of 200mM DTT and 5μL of Bulk Mix (cloned, FPLCpure Murine Reverse Transcriptase, RNAguard, RNAse / DNAse-Free BSA1). dATP, dCTP, dGTP and dTTP) The mixture was incubated for 1 hour at 37 ° C. Synthesized cDNAs were treated with 1U RNase H per reaction.
Oligonucleotídeo utilizado:Oligonucleotide used:
Not-dT: 5'-AACTGGAAGAATTCGCGGCCGCAGGAAT18-3'Not-dT: 5'-AACTGGAAGAATTCGCGGCCGCAGGAAT18-3 '
Exemplo 3.2.1: Primeira fita para análise de RT-PCR em tempo realExample 3.2.1: First Ribbon for Real-Time RT-PCR Analysis
A primeira fita de cDNA sintetizada usando o "Taqman First strand cDNA synthesis kit', foi feita em reações com volume final de 25μL, de acordo com o fabricante. Para cada 500ng de RNA total foram adicionados 2,5μL de TaqMan RT Buffer 10X, 5,5μL de 25mM MgCI2, 5 μL de dNTPs Mix, 1,25μL de Hexamero randômico, 0,5μL de RNase Inhibitor, 0,625μL de MultiScribe™ Reverse Transcriptase (501)/μL). As amostras foram incubadas a 25°C por 10 minutos, seguidos por 48°C por 30 minutos e um último passo de 95°C por 5 minutos. As amostras foram diluídas quatro vezes com 10mM de Tris-Cl pH 8,0 e armazenadas a -20°C ou prontamente utilizadas.The first cDNA strand synthesized using the 'Taqman First strand cDNA synthesis kit' was made in reactions with a final volume of 25μL, according to the manufacturer. For each 500ng of total RNA, 2.5μL of TaqMan RT Buffer 10X was added. 5.5μL 25mM MgCl2, 5μL dNTPs Mix, 1.25μL Random Hexamero, 0.5μL RNase Inhibitor, 0.625μL MultiScribe ™ Reverse Transcriptase (501) / μL The samples were incubated at 25 ° C for 10 minutes, followed by 48 ° C for 30 minutes and a final step of 95 ° C for 5 minutes The samples were diluted four times with 10mM Tris-Cl pH 8.0 and stored at -20 ° C or readily used.
Oligonucleotídeo utilizado: Hexamero randômico (Applied Biosystems)Oligonucleotide Used: Random Hexamer (Applied Biosystems)
Exemplo 3.3: Amplificação da molécula de cDNA.Example 3.3: Amplification of cDNA Molecule.
O PCR em tempo real foi realizado com o kit SYBR Green PCR Máster Mix, da empresa Applied Biosystems, conforme as recomendações do fabricante.Real-time PCR was performed using the SYBR Green PCR Master Mix kit from Applied Biosystems, according to the manufacturer's recommendations.
A reação foi feita em uma placa de 96 poços (MicroAmp Optical 96-Well Reaction Plate1 da empresa Applied Biosystems). Em cada poço foram colocadas 6,25μL da reação de primeira fita diluída 4 vezes, 12,5μL da solução mix do kit e 6,25μL de uma mistura dos dois oligonucleotídeos a 3,6μΜ cada um. Para cada reação que utilizava os oligonucleotídeos específicos para cada gene, foi feita outra com oligonucleotídeos específicos para o gene Ubiquitina 14 (UBI14), gene com expressão aproximadamente constitutiva em todas as células da planta. Esta reação foi utilizada como controle positivo e como normalizador da quantidade de primeira-fita de cDNA utilizada nos experimentos. Como controle negativo, foi feita uma reação nas mesmas condições do controle positivo sem o molde de primeira fita. A placa de 96 poços é colocada em um suporte, dentro da máquina de PCR (ABI Prism 7700, Applied Biosystems). Este suporte é responsável pela alteração da temperatura na placa, de acordo com o programa estabelecido. Uma lâmpada de tungstênio-halogênio ilumina a placa. À medida que o SyBr presente no mix é incorporado às novas fitas de DNA, ele emite uma fluorescência quando excitado pela iluminação da lâmpada. A luz que vem da placa reflete através de 4 filtros ópticos, cada um com uma cor diferente (amarelo, azul, verde e vermelho). Uma câmera acoplada ao aparelho converte a intensidade de fluorescência das cores em dados quantitativos. O programa ABl Prism 7000 SDS Software reúne todos os componentes dos dados de cada amostra, determinando a intensidade total de cada uma delas. O resultado bruto do software do PCR em tempo real é uma curva logarítmica da intensidade de fluorescência na fase inicial, que se transforma, gradativamente, num platô de saturação. Para determinarmos a quantidade precisa do produto de PCR, é imprescindível que o ponto de medição seja bem determinado. É preciso desconsiderar o sinal inicial, que pode conter fluorescência basal. Esta é muito evidente nos ciclos iniciais, antes de haver uma quantidade significativa do DNA amplificado. É baseado nestes ciclos que se determina a linha de fluorescência básica das amostras. O ponto de medição escolhido foi acima da linha de base, ainda na fase logarítmica da curva.The reaction was performed in a 96-well plate (MicroAmp Optical 96-Well Reaction Plate1 from Applied Biosystems). In each well were placed 6.25μL of the 4-fold diluted first reaction, 12.5μL of the kit's mix solution and 6.25μL of a mixture of the two oligonucleotides at 3.6μΜ each. For each reaction using the specific oligonucleotides for each gene, another was made with oligonucleotides specific for the Ubiquitin 14 gene (UBI14), a gene with approximately constitutive expression in all cells of the plant. This reaction was used as a positive control and as a normalizer for the amount of cDNA first strand used in the experiments. As a negative control, a reaction was performed under the same conditions as the positive control without the first ribbon mold. The 96-well plate is placed in a rack inside the PCR machine (ABI Prism 7700, Applied Biosystems). This bracket is responsible for changing the temperature on the board according to the established program. A tungsten-halogen lamp illuminates the plate. As SyBr in the mix is incorporated into the new DNA strands, it emits fluorescence when excited by lamp illumination. The light coming from the plate reflects through 4 optical filters, each with a different color (yellow, blue, green and red). A camera attached to the device converts the fluorescence intensity of colors into quantitative data. The ABl Prism 7000 SDS Software program brings together all the data components of each sample, determining the total intensity of each one. The raw result of the real-time PCR software is a logarithmic curve of the fluorescence intensity in the early phase, which gradually becomes a saturation plateau. In order to determine the precise quantity of the PCR product, it is essential that the measurement point is well determined. You need to disregard the initial signal, which may contain basal fluorescence. This is very evident in the early cycles, before there is a significant amount of amplified DNA. It is based on these cycles that the basic fluorescence line of the samples is determined. The measurement point chosen was above the baseline, still in the logarithmic phase of the curve.
O ponto de medição determina o número de ciclos necessários para gerar a fluorescência no ponto escolhido. Os valores obtidos são transformados para uma escala linear, utilizando-se a base 2 por serem duas fitas moldes de DNA (reação exponencial). O resultado obtido é a quantidade de fluorescência encontrada naquele determinado número de ciclos, em unidade arbitrária. O valor da fluorescência de cada amostra com os oligonucleotídeos específicos dos genes em questão é, então, dividido pela fluorescência da amostra correspondente com o oligonucleotídeo UBI14. Assim, as amostras são normalizadas pela quantidade de primeira-fita. Depois deste cálculo feito, divide-se o valor de cada amostra pelo valor da amostra controle. Deste modo obtemos o valor de quantas vezes mais a amostra expressa o gene em questão em relação ao controle do experimento.The measuring point determines the number of cycles required to generate fluorescence at the chosen point. The values obtained are transformed to a linear scale, using base 2 as two DNA strands (exponential reaction). The result obtained is the amount of fluorescence found at that given number of cycles in arbitrary unit. The fluorescence value of each sample with the specific oligonucleotides of the genes in question is then divided by the fluorescence of the corresponding sample with the UBI14 oligonucleotide. Thus, the samples are normalized by the amount of first tape. After this calculation is made, the value of each sample is divided by the value of the control sample. Thus we get the value of how many times the sample expresses the gene in question in relation to the control of the experiment.
Fl. Rel. = 2(CT Ubi-CT gene)Fl. Rel. = 2 (CT Ubi-CT gene)
Onde, Fl. Rel. é a fluorescência relativa. CT ubi é a média de número de ciclos no ponto escolhido do controle com UBI14.Where, Fl. Rel. Is the relative fluorescence. CT ubi is the average number of cycles at the chosen control point with UBI14.
CT gene é a média de número de ciclos no ponto escolhido da curva em questão.CT gene is the average number of cycles at the chosen point of the curve in question.
Para expressão relativa dos experimentos com os controles experimentais, então: Fl. Rel. exp / Fl. Rel. contFor relative expression of experiments with experimental controls, then: Fl. Exp / Fl. Count Count
EXEMPLO 3.4: Clonagem utilizando o sistema Gateway® (Invitrogen®)EXAMPLE 3.4: Cloning Using the Gateway® System (Invitrogen®)
Embora possa ser utilizados quaisquer tipo de sistemas de clonagem comercialmente disponíveis, exemplificaremos somente a clonagem realizada com o emprego do sistema Gateway® (Invitorgen®). Este sistema baseia-se na transferência de uma ou mais seqüências de DNA para múltiplos vetores em reações paralelas, enquanto mantém a mesma orientação e código de leitura. Para isto, a técnica utiliza sítios específicos de recombinação (att) do fago λ e um conjunto de enzimas denominadas recombinases. O sistema de clonagem é constituído por duas etapas: a reação LR e a reação BP. A reação BP é uma reação de recombinação, catalisada pela "BP Clonase Enzyme Mix", entre um produto de PCR ou um clone de expressão e o vetor doador (neste trabalho pDONR201 e pDONR221). Esta reação serve para criar um vetor de entrada ("entry-clone') a partir de um vetor doador. A partir do clone de entrada pode-se transferir o DNA para qualquer vetor Gateway. Para que haja a inserção do gene de interesse no vetor doador, é necessário acrescentar regiões de recombinação nos oligonucleotídeos específicos. Assim, o produto final da reação de PCR estará flanqueado pelas seqüências de recombinação attB1 e atfB2. Quando ocorrer a reação BP, o vetor doador (que possui regiões affP1 e attP2) irá recombinar com o produto do PCR (que possui regiões attB1 e attQ2) e formará um vetor de entrada contendo as regiões aííL1 e attL2 (Figura XX). Isto garante a orientação correta da ORF após a reação.While any type of commercially available cloning systems may be used, we will only exemplify cloning performed using the Gateway® (Invitorgen®) system. This system is based on the transfer of one or more DNA sequences to multiple vectors in parallel reactions while maintaining the same orientation and reading code. For this, the technique uses specific recombination sites (att) of phage λ and a set of enzymes called recombinases. The cloning system consists of two steps: the LR reaction and the BP reaction. The BP reaction is a recombination reaction, catalyzed by the BP Clonase Enzyme Mix, between a PCR product or an expression clone and the donor vector (pDONR201 and pDONR221). This reaction serves to create an entry-clone from a donor vector. From the input clone one can transfer the DNA to any Gateway vector. donor vector, recombination regions need to be added to specific oligonucleotides, so the end product of the PCR reaction will be flanked by the attB1 and atfB2 recombination sequences. When the BP reaction occurs, the donor vector (which has affP1 and attP2 regions) recombine with the PCR product (which has attB1 and attQ2 regions) and will form an input vector containing the A 1L1 and attL2 regions (Figure XX) This ensures the correct orientation of the ORF after the reaction.
As condições usadas na amplificação dos cDNAs do AtAPC7 e AtAPC7 splicing foram (tabela 1) (1°PCR):The conditions used in amplifying AtAPC7 and AtAPC7 splicing cDNAs were (Table 1) (1st PCR):
<table>table see original document page 14</column></row><table><table> table see original document page 14 </column> </row> <table>
Tabela 1: Protocolo da reação do 1° PCR para clonagem em vetores Gateway.Table 1: 1st PCR reaction protocol for cloning in Gateway vectors.
Tampão da enzima Pfx (50mM Tris-Cl pH 8.0, 50mM KCI, 1mM DTT, 0.1mM EDTA, estabilizadores e glicerol a 50%).Pfx enzyme buffer (50mM Tris-Cl pH 8.0, 50mM KCI, 1mM DTT, 0.1mM EDTA, stabilizers and 50% glycerol).
A reação ocorreu em um termociclador Mastercycler® (Eppendorf), utilizando as seguintes condições (tabela 2): <table>table see original document page 15</column></row><table>The reaction occurred in a Mastercycler® (Eppendorf) thermal cycler using the following conditions (table 2): <table> table see original document page 15 </column> </row> <table>
Tabela 2: Parâmetros empregados na 1a reação de PCR.Table 2: Parameters used in the 1st PCR reaction.
As amplificações por PCR de algumas ORFs deste trabalho foram realizadas utilizando apenas um par de oligonucleotídeos específicos, contendo toda a seqüência adaptadora da região de recombinação attB. Com a inclusão da região de recombinação nos oligonucleotídeos específicos, somente uma reação de PCR é necessária (oligonucleotídeos com 60 nucleotídeos).PCR amplifications of some ORFs of this work were performed using only one pair of specific oligonucleotides containing the entire attB recombination region adapter sequence. With the inclusion of the recombination region in the specific oligonucleotides, only one PCR reaction is required (60 nucleotide oligonucleotides).
Entretanto, para a amplificação de algumas ORFs, uma segunda reação de PCR foi realizada utilizando o produto do primeiro PCR como molde. Oligonucleotídeos contendo a região adaptadora, inclusive parte da região existente no primeiro par de oligonucleotídeos específicos, foram utilizados para gerar um produto final contendo a região de recombinação attB).However, for the amplification of some ORFs, a second PCR reaction was performed using the first PCR product as a template. Oligonucleotides containing the adapter region, including part of the region in the first pair of specific oligonucleotides, were used to generate an end product containing the recombination region (attB).
Na segunda amplificação (tabela 3) (2o PCR), os seguintes parâmetros foram usados:In the second amplification (table 3) (2nd PCR), the following parameters were used:
<table>table see original document page 15</column></row><table><table> table see original document page 15 </column> </row> <table>
Tabela 3: Parâmetros empregados na 2a reação de PCR.Table 3: Parameters used in the 2nd PCR reaction.
O fragmento de DNA de interesse, após a purificação, foi clonado no vetor pDONR201/221 (Invitrogen) em uma reação denominada BP (tabela 4). A reação BP foi incubada a 25°C por 12 horas e posteriormente dialisada durante 3 horas em membrana 0,025μm (Millipore). Após a diálise, a reação foi utilizada para transformar E. coli DH5a por eletroporação. As colônias resistentes a 50μg/mL de kanamicina foram inoculadas em meio LB líquido acrescido deste antibiótico. A extração do DNA plasmidial foi feita utilizando o kit "GFX Piasmid Minipreparation" (GE Healthcare) seguindo as instruções do fabricante. Uma vez confirmado por digestão e por sequenciamento, este novo plasmídeo passa a ser chamado de clone de entrada.The DNA fragment of interest, after purification, was cloned into the pDONR201 / 221 vector (Invitrogen) in a reaction called BP (Table 4). The BP reaction was incubated at 25 ° C for 12 hours and then dialyzed for 3 hours in 0.025μm membrane (Millipore). After dialysis, the reaction was used to transform E. coli DH5a by electroporation. Colonies resistant to 50μg / mL kanamycin were inoculated into liquid LB medium plus this antibiotic. Plasmid DNA extraction was performed using the "GFX Piasmid Minipreparation" kit (GE Healthcare) following the manufacturer's instructions. Once confirmed by digestion and sequencing, this new plasmid is called an input clone.
<table>table see original document page 16</column></row><table><table> table see original document page 16 </column> </row> <table>
Tabela 4: Componentes da reação BP. Reações com volume final de 5μL.Table 4: Components of the BP reaction. Reactions with final volume of 5μL.
A reação LR ocorreu a partir do clone de entrada pode-se transferir o DNA para qualquer vetor de expressão Gateway. A reação LR é justamente a recombinação entre o vetor de entrada do sistema e o vetor de destino (Figura 10). Esta reação é catalisada pela "LR Clonase Enzyme Mix". As regiões attL1 e atíL2 presentes no vetor de entrada (formado pela reação BP) e as regiões attR1 e attR2 presentes nos vetores de destino serão recombinadas e surgirá o clone de expressão. O clone de expressão resultante possui os sítios affB1 e attB2 idênticos aos presentes nos produtos de PCR. Neste trabalho, os vetores de destino utilizados foram pK7WG2, pK7WGF2 e pK7GW43DNew.The LR reaction occurred from the input clone and the DNA can be transferred to any Gateway expression vector. The LR reaction is precisely the recombination between the system input vector and the target vector (Figure 10). This reaction is catalyzed by the "LR Clonase Enzyme Mix". The attL1 and atL2 regions present in the input vector (formed by the BP reaction) and the attR1 and attR2 regions present in the target vectors will be recombined and the expression clone will appear. The resulting expression clone has the affB1 and attB2 sites identical to those present in PCR products. In this work, the target vectors used were pK7WG2, pK7WGF2 and pK7GW43DNew.
A reação LR deve ser incubada a 25°C por 12 horas e posteriormente dialisada durante 3 horas em membrana 0,025μ m (Millipore). Após a diálise, a reação foi utilizada para transformar E. coli DH5a por eletroporação. As colônias resistentes aos antibióticos exigidos pela seleção do vetor foram inoculadas em meio LB líquido acrescido dos antibióticos específicos. A extração do DNA plasmidial foi feita utilizando o kit "GFX Plasmid Minipreparation" (GE Healthcare) seguindo as instruções do fabricante. Uma vez confirmado por digestão, este novo plasmídeo passa a ser chamado de clone de destino.The LR reaction should be incubated at 25 ° C for 12 hours and then dialyzed for 3 hours in 0.025μm membrane (Millipore). After dialysis, the reaction was used to transform E. coli DH5a by electroporation. Antibiotic resistant colonies required by vector selection were inoculated into liquid LB medium plus specific antibiotics. Plasmid DNA extraction was performed using the "GFX Plasmid Minipreparation" kit (GE Healthcare) following the manufacturer's instructions. Once confirmed by digestion, this new plasmid is now called the target clone.
Os vetores doadores e os vetores de destino contêm o gene ccdB flanqueado pelas regiões de recombinação. Por codificar uma proteína letal para as bactérias utilizadas nos experimentos, funciona como um agente inibidor de falsos positivos. Caso não ocorra a recombinação, as bactérias transformadas com estes vetores falharão no momento da replicação do DNA. Assim, qualquer falha na recombinação entre os vetores não resultará em clones viáveis.Donor vectors and target vectors contain the ccdB gene flanked by the recombination regions. By coding a lethal protein for the bacteria used in the experiments, it works as a false positive inhibitor. If recombination does not occur, bacteria transformed with these vectors will fail at the time of DNA replication. Thus, any recombination failure between the vectors will not result in viable clones.
Exemplo 3.4.1: Comprovação da amplificação:Example 3.4.1: Proof of Amplification:
Os produtos das reações de PCR, digestões e ligações foram eletroforeticamente separados em gel de agarose 1,0%, preparado em tampão TAE (80mM Tris-base; 80mM ácido acético; 2mM EDTA pH 8,0) e brometo de etídeo (0,5pg/mL). O gel foi colocado na cuba de eletroforese i-Mupid®, imerso em TAE 0,5X e submetido a 100V por 30 minutos.The PCR reaction products, digestions and ligations were electrophoretically separated on 1.0% agarose gel prepared in TAE buffer (80mM Tris-base; 80mM acetic acid; 2mM EDTA pH 8.0) and ethidium bromide (0, 5pg / mL). The gel was placed in the i-Mupid® electrophoresis vat, immersed in 0.5X TAE and subjected to 100V for 30 minutes.
Exemplo 3.4.2: Extração do DNA do Gel de Agarose:Example 3.4.2: DNA Extraction from Agarose Gel:
Para purificar o fragmento de DNA do gel, foi utilizado o Kit "GFX PCR DNA and Gel Band Purification" (GE Healthcare) de acordo com as instruções do fabricante.To purify the DNA fragment of the gel, the GFX PCR DNA and Gel Band Purification Kit (GE Healthcare) was used according to the manufacturer's instructions.
As bandas desejadas foram cortadas do gel com o auxílio de uma lâmina de bisturi. Estas bandas foram colocadas em um tubo de microcentrífuga de 1,5mL. Para cada 10mg de gel foram adicionados 10μL de tampão de captura e os tubos incubados a 60°C (até que a agarose fosse completamente dissolvida). A amostra foi transferida para a coluna GFX acoplada a um tubo de microcentrífuga de 1,5mL e incubada por 1 minuto à temperatura ambiente. O sistema tubo/coluna foi então centrifugado por 30 segundos a 20.000g e o líquido descartado. Foram adicionados 500μL de tampão de lavagem à coluna de purificação e posteriormente esta foi centrifugada por 30 segundos a 20.000g. A coluna foi transferida para um novo tubo de microcentrífuga de 1,5mL. Foram adicionados 30μL de água Milli-Q a coluna. Após centrifugação, a solução contendo o DNA eluído do gel foi estimada através de eletroforese em gel de agarose 1%.The desired bands were cut from the gel with the aid of a scalpel blade. These bands were placed in a 1.5mL microcentrifuge tube. For each 10mg of gel, 10μL of capture buffer was added and the tubes incubated at 60 ° C (until the agarose was completely dissolved). The sample was transferred to the GFX column coupled to a 1.5mL microcentrifuge tube and incubated for 1 minute at room temperature. The tube / column system was then centrifuged for 30 seconds at 20,000g and the liquid discarded. 500μL of wash buffer was added to the purification column and then centrifuged for 30 seconds at 20,000g. The column was transferred to a new 1.5mL microcentrifuge tube. 30μL of Milli-Q water was added to the column. After centrifugation, the solution containing the gel-eluted DNA was estimated by 1% agarose gel electrophoresis.
Exemplo 3.4.3. Transformação de Agrobacterium tumefaciens:Example 3.4.3. Agrobacterium tumefaciens transformation:
A transformação de Agrobacterium tumefaciens consiste numa brusca alternância de temperatura (caracterizando o choque térmico). Adicionou-se 1μg de DNA na alíquota de células competentes (200μL). O tubo de microcentrífuga contendo a ligação e as células foram colocadas em gelo por 30 minutos em seguida foi colocado em nitrogênio líquido por 2 minutos. Depois, o tubo foi incubado a 37°C por 5 minutos. A solução foi transferida para um tubo de 15mL contendo 1mL de YEB e incubado por 1 hora a 30°C sob agitação. Ao final do período, a suspensão celular foi semeada em placa contendo YEB sólido com o antibiótico adequado.The transformation of Agrobacterium tumefaciens is a sudden change in temperature (characterizing thermal shock). 1μg of DNA was added to the aliquot of competent cells (200μL). The microcentrifuge tube containing the binding and the cells were placed on ice for 30 minutes then placed in liquid nitrogen for 2 minutes. Then the tube was incubated at 37 ° C for 5 minutes. The solution was transferred to a 15mL tube containing 1mL YEB and incubated for 1 hour at 30 ° C with shaking. At the end of the period, the cell suspension was seeded in a plate containing solid YEB with the appropriate antibiotic.
Exemplo 3.4.3 (b). Transformação genética de Arabidopsis thaliana - Ecotipo ColumbiaExample 3.4.3 (b). Genetic transformation of Arabidopsis thaliana - Columbia Ecotype
Para a obtenção de plantas transfectadas de Arabidopsis thaliana foi utilizado o método de transformação in vivo (Floral dip) (CLOUGH e BENT, 1998), usando A. tumefasciens (linhagem C58C1Rif - PMP90). Resumidamente, sementes de A. thaliana do ecotipo Columbia foram incubadas por 2-3 dias a 4°C em 27,5 mL de agar 0,2%. A seguir, foram germinadas por duas semanas em uma mistura de areia:solo (1:3) e as plântulas obtidas foram transplantadas para potes individuais. Cada pote com uma inflorescência de 7-10 cm de altura foi usado para transformação. As inflorescências foram invertidas e agitadas por 3 seg em uma cultura de Agrobacterium tumefaciens transformada com os clones de interesse. A seguir as plantas foram mantidas a 22°C/dia, 18°C/noite com um fotoperíodo de 12h de luz e 12h de escuro em um sistema Aracon. Cinco semanas após a transformação, as plantas foram transferidas para uma temperatura de 25°C e, após duas semanas, as sementes foram coletadas e estocadas a 4°C para posterior análise da geração F2. O material transformado foi semeado em meio seletivo específico.To obtain transfected plants of Arabidopsis thaliana, the in vivo transformation method (Floral dip) (CLOUGH and BENT, 1998) was used, using A. tumefasciens (C58C1Rif - PMP90 strain). Briefly, A. thaliana seeds of the Columbia ecotype were incubated for 2-3 days at 4 ° C in 27.5 mL of 0.2% agar. They were then germinated for two weeks in a sand: soil (1: 3) mixture and the seedlings obtained were transplanted to individual pots. Each pot with a 7-10 cm inflorescence height was used for transformation. The inflorescences were inverted and shaken for 3 sec in a culture of Agrobacterium tumefaciens transformed with the clones of interest. The plants were then maintained at 22 ° C / day, 18 ° C / night with a 12h light and 12h dark photoperiod in an Aracon system. Five weeks after transformation, the plants were transferred to a temperature of 25 ° C and, after two weeks, the seeds were collected and stored at 4 ° C for further analysis of F2 generation. The transformed material was sown in specific selective medium.
Nestes transformantes foram feitas as seguintes analises, sempre compradas com o controle: forma da folha, estrutura da flor, estrutura da silíqüa e sementes e o crescimento radicular.The following analyzes were performed on these transformants, always purchased with the control: leaf shape, flower structure, silica and seed structure and root growth.
Exemplo 3.5. Transformação genética de Nicotiana tabacum variedade SR1:Example 3.5. Genetic transformation of Nicotiana tabacum variety SR1:
Para estudar o papel da Seq.ld. 1 e da Seq.ld 2 no desenvolvimento das plantas, foi escolhido o vetor de superexpressão pK7GW43DNew. O vetor possui o promotor 35S do vírus do mosaico da couveflor, uma cauda de HA e regiões denominadas LB e RB. O promotor 35S contém muitos elementos regulatórios, o que permite uma elevada taxa de transcrição gênica. As regiões LB e RB flanqueiam a região de superexpressão do vetor (35S::ORF::HA) e são necessárias para a transferência dessa unidade funcional do vetor para o genoma da planta via Agrobacterium sp. Antes de realizar a transformação de tabaco, é necessário fazer um pré-inóculo contendo Agrobacterium tumefaciens transformada com os antibióticos adequados em meio YEB. O pré- inóculo deve ser mantido a 28°C sob agitação por 48 horas. As bactérias utilizadas para a transformação de tabaco continham as construções de superexpressão das SEq.Id 1 e Seq.Id. 2 de Arabidopsis thaliana. Os antibióticos usados nos pré-inóculos foram Sp, Sm, Rf e Gm.To study the role of Seq.ld. 1 and Seq.ld 2 in plant development, the overexpression vector pK7GW43DNew was chosen. The vector has the cauliflower mosaic virus 35S promoter, a HA tail, and regions called LB and RB. The 35S promoter contains many regulatory elements, which allows a high rate of gene transcription. The LB and RB regions flank the vector overexpression region (35S :: ORF :: HA) and are required for the transfer of this vector functional unit to the plant genome via Agrobacterium sp. Prior to tobacco transformation, a pre-inoculum containing Agrobacterium tumefaciens transformed with the appropriate antibiotics in YEB medium must be made. The pre-inoculum should be kept at 28 ° C under agitation for 48 hours. The bacteria used for tobacco processing contained the overexpression constructs of SEq.Id 1 and Seq.Id. 2 of Arabidopsis thaliana. The antibiotics used in the pre-inocula were Sp, Sm, Rf and Gm.
As plantas utilizadas foram da variedade SR1 de Nicotiana tabacum. Em fluxo laminar, as folhas de tabaco foram cortadas com bisturi estéril na forma de um quadrado de 1cm2 sem fragmentos da nervura central. Estes explantes foliares foram expostos por 10 minutos aos respectivos inóculos. Após esse período, os explantes foram colocados na superfície das placas de MS sólido contendo os hormônios IAA e 6BA. As placas foram deixadas na sala de cultura in vitro por 2 dias a 28°C e fotoperíodo de 12 horas. Posteriormente, os explantes foram transferidos para uma nova placa de MS sólido contendo IAA, 6BA, cefotaxima e kanamicina (o antibiótico cefotaxima atua inibindo o crescimento da Agrobacterium sp e o antibiótico kanamicina atua selecionando as plantas transformadas). Ao término da transferência, as placas foram novamente colocadas na sala de cultura in vitro até o aparecimento de calos na superfície dos explantes. Os calos foram separados e transferidos para um novo meio MS contendo IAA (indução do enraizamento e crescimento da parte aérea dos brotos oriundos de cada calo). Após o período de desenvolvimento no meio MS/IAA, as plantas foram transferidas (propagação vegetativa) para o meio seletivo MS/Km. As plantas que conseguiram enraizar foram transferidas para vasos contendo terra e vermiculita (2:1). Estes vasos foram colocados na sala in vivo a 28°C sob fotoperíodo de 12 horas de !uz. Vale ressaltar que explantes foliares não transformados de SR1 (controle) também passaram pela cultura de tecidos (meio MS/IAA/6BA e meio MS/IAA) até serem transferidos para vasos contendo terra e vermiculita (2:1).The plants used were from the variety SR1 of Nicotiana tabacum. In laminar flow, the tobacco leaves were cut with a sterile scalpel in the form of a 1cm2 square without central rib fragments. These leaf explants were exposed for 10 minutes to their inoculum. After this period, the explants were placed on the surface of solid MS plates containing the hormones IAA and 6BA. The plates were left in the culture room in vitro for 2 days at 28 ° C and 12 hours photoperiod. Subsequently, the explants were transferred to a new solid MS plate containing IAA, 6BA, cefotaxime and kanamycin (cefotaxime antibiotic acts by inhibiting the growth of Agrobacterium sp and kanamycin antibiotic acts by selecting the transformed plants). At the end of the transfer, the plates were again placed in the culture room in vitro until calluses appeared on the explants surface. The calli were separated and transferred to a new MS medium containing IAA (rooting induction and shoot growth from each callus). After the development period in MS / IAA medium, the plants were transferred (vegetative propagation) to MS / Km selective medium. Rooting plants were transferred to pots containing soil and vermiculite (2: 1). These vessels were placed in the room in vivo at 28 ° C under 12 hour photoperiod. It is noteworthy that untransformed SR1 leaf explants (control) also underwent tissue culture (MS / IAA / 6BA medium and MS / IAA medium) until transferred to pots containing soil and vermiculite (2: 1).
Exemplo 4.Obtenção de plantas transformadas:Example 4. Obtaining transformed plants:
Após a obtenção das linhagens transformadas in vitro (geração TO), as plantas superexpressando as Seq.ld 1 e Seq.ld 2 foram transferidas para a terra até gerarem sementes por autofecundação (geração T1). As sementes foram coletadas, esterilizadas e guardadas a 4°C. A partir da semeadura de 100 sementes de cada linhagem transformada em MS/Km, foi possível determinar a segregação mendeliana. Para verificar se o agente seletor estaria ou não influenciando no fenótipo, 50 sementes foram semeadas em MS sem antibiótico. A partir da placa MS/Km, 5 plantas de cada linhagem foram transferidas para o vaso contendo terra e vermiculita na casa in vivo. A autofecundação dessas plantas resultou em sementes correspondentes a geração T2, Estas sementes foram esterilizadas, guardadas a 4°C e semeadas em meio MS/Km para determinar sua segregação (homozigotas ou hemizigotas), vide figura XX.After obtaining the in vitro transformed strains (TO generation), plants overexpressing Seq.ld 1 and Seq.ld 2 were transferred to soil until they generated seeds by self-fertilization (T1 generation). The seeds were collected, sterilized and stored at 4 ° C. From the sowing of 100 seeds of each strain transformed in MS / Km, it was possible to determine the Mendelian segregation. To verify whether or not the selector agent was influencing the phenotype, 50 seeds were sown in DM without antibiotic. From the MS / Km plate, 5 plants of each strain were transferred to the pot containing soil and vermiculite in the house in vivo. Self-fertilization of these plants resulted in seeds corresponding to T2 generation. These seeds were sterilized, stored at 4 ° C and sown in MS / Km medium to determine their segregation (homozygotes or hemizigotes), see Figure XX.
Exemplo 5. Verificação de massa fresca e seca das plantas de tabaco:Example 5. Verification of fresh and dry mass of tobacco plants:
As folhas e o caule de cada tabaco foram coletados e imediatamente pesados em balança de precisão. Os resultados obtidos representavam os valores de massa fresca. Posteriormente, o material vegetal era incubado em estufa de secagem a 70°C por 3 dias. O material seco era pesado e os valores correspondiam à massa seca.The leaves and stem of each tobacco were collected and immediately weighed on a precision scale. The obtained results represented the values of fresh mass. Subsequently, the plant material was incubated in a drying oven at 70 ° C for 3 days. The dried material was weighed and the values corresponded to the dry mass.
Exemplo 6. Cálculo da área foliar:Example 6. Leaf area calculation:
O comprimento e a largura das lâminas foliares foram medidas com o auxílio de uma régua. O comprimento foi medido desde a ponta da folha até o pecíolo. A largura medida foi a maior distância, ou seja, a região central da folha. Os resultados foram multiplicados para obter a área foliar bruta.The length and width of the leaf blades were measured with the aid of a ruler. Length was measured from leaf tip to petiole. The measured width was the largest distance, ie the central region of the leaf. Results were multiplied to obtain gross leaf area.
Exemplo 7.Análise estatística das plantas de tabaco:Example 7. Statistical analysis of tobacco plants:
As análises estatísticas foram realizadas utilizando o programa GraphPad Prism versão 3 (GraphPad Software Incorporated). Cada análise estatística foi realizada com um número de amostras igual a 12 (plantas) por construção/linhagem. Os valores extremos obtidos (valor máximo e mínimo) foram descartados. Os experimentos foram realizados em duplicata. Os dados obtidos foram submetidos à análise de variância e feito o teste Turkey para comparação de médias. O teste Turkey permite estabelecer a diferença mínima significante, ou seja, a menor diferença de médias de amostras que deve ser tomada como estatisticamente significante, em determinado nível.Statistical analyzes were performed using GraphPad Prism version 3 software (GraphPad Software Incorporated). Each statistical analysis was performed with a number of samples equal to 12 (plants) per building / lineage. The extreme values obtained (maximum and minimum values) were discarded. The experiments were performed in duplicate. The obtained data were submitted to the analysis of variance and the Turkey test for comparison of means. The Turkey test allows to establish the minimum significant difference, that is, the smallest difference in sample means that should be taken as statistically significant at a given level.
Exemplo 8. Experimento de Agroinfiltração:Example 8. Agroinfiltration Experiment:
Inoculo das construções contendo a Seq.Id 1 e a Seq.Id 2 e TMV::GFP em A. tumefaciens foram feitos em meio YEB com o respectivos antibióticos e incubados a 28°C por 48 horas. A cultura foi centrifugada a 4°C por 3 minutos a 3.000g rpm. O sobrenadante foi descartado e o precipitado ressuspenso em 10mM de MgSO4. A cultura foi novamente centrifugada a 4°C por 3 minutos a 3.000g rpm. O sobrenadante foi descartado e o precipitado diluído em uma solução de acetoceringona (1-2 μL/10mL) até chegar a D0600= 1.0. O preparado foi mantido 3 horas à temperatura ambiente antes de agroinfiltrar.Inoculum of constructs containing Seq.Id 1 and Seq.Id 2 and TMV :: GFP in A. tumefaciens were made in YEB medium with the respective antibiotics and incubated at 28 ° C for 48 hours. The culture was centrifuged at 4 ° C for 3 minutes at 3,000g rpm. The supernatant was discarded and the precipitate resuspended in 10mM MgSO4. The culture was again centrifuged at 4 ° C for 3 minutes at 3,000g rpm. The supernatant was discarded and the precipitate diluted in acetoceringone solution (1-2 μL / 10mL) until reaching D0600 = 1.0. The preparation was kept for 3 hours at room temperature before agroinfiltrating.
Plantas de N.tabacum variedade Samsun nn com 45 dias foram agroinfiltradas da seguinte forma:Plants of N.tabacum variety Samsun nn with 45 days were agroinfiltrated as follows:
1° dia: Inoculo da construção TMV::GFP;Day 1: Inoculum of TMV :: GFP construction;
3° dia: Inoculo das construções contendo a Seq.Id 1 e Seq.Id 2 (tratamentos distintos);Day 3: Inoculum of constructs containing Seq.Id 1 and Seq.Id 2 (distinct treatments);
5° dia: Analise das plantas sob luz ultravioleta para ver o nível de infecção viral;Day 5: Analysis of plants under ultraviolet light to see the level of viral infection;
10° dia: Analise das plantas sob luz ultravioleta para ver o nível de infecção viral;Day 10: Analysis of plants under ultraviolet light to see level of viral infection;
15° dia: Analise das plantas sob luz ultravioleta para ver o nível de infecção viral;Day 15: Analysis of plants under ultraviolet light to see level of viral infection;
Todos os tratamentos foram feitos em triplicata e como controle do experimento foi agroinfiltrada somente A. tumefaciens não transformada e A. tumefaciens não transformadas seguida pela agroinfiltração das construções contendo a a Seq.Id 1 e a Seq.Id 2 (tratamentos distintos).All treatments were done in triplicate and as control of the experiment only A. non-transformed A. tumefaciens and A. non-transformed A. tumefaciens were agroinfiltrated followed by agroinfiltration of the constructs containing a Seq.Id 1 and Seq.Id 2 (separate treatments).
Exemplo 9. Análise das Seqüências de DNA:Example 9. DNA Sequence Analysis:
As análises das seqüências de nucleotídeos e aminoácidos foram realizadas utilizando o conjunto de programas BLAST (Basic Local Alignment Search Toof), disponibilizado na internet pelo NCBI (National Center for Bioinformatics and Information - http://www.ncbi.nlm.nih.gov) (Altschul, et al, 1997) e pela ferramenta de múltiplo alinhamento Clustal W ( www .ebi.ac.uk/ clustalw /).Nucleotide and amino acid sequence analyzes were performed using the Basic Local Alignment Search Toof (BLAST) suite of programs available on the Internet from the National Center for Bioinformatics and Information (NCBI) - http://www.ncbi.nlm.nih.gov ) (Altschul, et al, 1997) and the Clustal W multi-alignment tool (www .ebi.ac.uk / clustalw /).
A seqüência primária de proteína foi analisada quanto à homologia através do programa BLASTp (www.ncbi.nlm.nih.gov/BLAST) (Atschul, 1997). O programa Pfam (www.pfam.wustl.edu) foi utilizado como ferramenta para encontrar domínios com função biológica estabelecida.The primary protein sequence was analyzed for homology through the BLASTp program (www.ncbi.nlm.nih.gov/BLAST) (Atschul, 1997). The Pfam program (www.pfam.wustl.edu) was used as a tool to find domains with established biological function.
Para construção de árvores filogenéticas foi utilizado o programa Molecular Evolutionary Genetics Analyses, versão 3 - Mega 3 (Kumar et al, 2004). As buscas no genoma de Arabidopsis foram feitas utilizando as ferramentas disponíveis no banco de dados TAIR de A. thaliana (www.arabidopsis.org). sequencias_ST25 SEQUENCE LISTINGFor the construction of phylogenetic trees, the Molecular Evolutionary Genetics Analyzes program, version 3 - Mega 3 (Kumar et al, 2004) was used. Searches in the Arabidopsis genome were done using the tools available in A. thaliana's TAIR database (www.arabidopsis.org). sequences_ST25 SEQUENCE LISTING
<110> UNIVERSIDADE FEDERAL DO RIO DE JANEIRO<110> RIO DE JANEIRO FEDERAL UNIVERSITY
<120> MÉTODO DE PROMOÇÃO DO AUMENTO EXACERBADO DA BIOMASSA VEGETAL<120> METHOD FOR PROMOTING THE EXACREBED VEGETABLE BIOMASS INCREASE
<130> crescimento vegetal<130> plant growth
<160> 2<160> 2
<170> Patentln version 3.5<170> Patentln version 3.5
<210> 1<210> 1
<211> 1757<211> 1757
<212> DNA<212> DNA
<213> Arabidopsis thaliana<213> Arabidopsis thaliana
<400> 1<400> 1
atggaggttc caaaggagca gatcgcgact ttaatagagc atgggcttta cgattctgct 60 gaaatgctcg gctgctttct cgtttcttct cctactgtta gtgccgaaac tagtcctcag 120 ctcaaggcgg agaatttgat tctactgggt gatgctttat ttcatcagag agaacaccgg 180 agagctattc atacgtacaa gcaagcgttg catcattaca caaggattcc gaagcaaagc 240 tccggtattt cgaggagttc attatcttta tctaccagat catctgtgaa tgcctccagc 300 atttctgcta ttaatgagaa cgaggtgaga ttcaagattg cttcatctca ctttgctctt 360 aatgaaacaa aagctgcgat tgctgagatg gaatctgtca agaccaggag cttagagatg 420 aatatactga tggcaaagct tcatcgaaat tctggataca accgtggtgc tattgctttt 480 tataaagagt gtttaaggca gtgtccttat gtacttgaag ccgtcatagg tttagctgaa 540 ctgggagtta gtgcaaagga tatcatatca tcgtttactc agacttcaaa tagaagtgca 600 aaggtttcac tcgatcagat agatcctacc cgctggttgc aacgttatgt agaggcccag 660 tgttgtgttg cttcgcatgc ttacaaaggg gcgctggaac tctttgctga actcttacaa 720 cgatttccaa ataatgtaca cttgttgact gagacagcaa aggttgaagc cattattggg 780 aaaaatgatg aggccataat gagatttgag aaggttcggt caattgatcc ttacacacta 840 accagtatgg atgagtatgc gatgctgctt cagattaagt gtgattattc caggctaaac 900 aagctcgtcc acgatttatt aagcgttgat cataccagag cagaagtatt tgttgctttg 960 tctgtactat gggaaaggaa agatgcaagg acggcattat cttatgctga gaagagtatc 1020 agggtagacg agaggcacat acccggctac ataatgaagg gaaatctact tttacaagca 1080 aaacgaccag aagctgcagc gatcgccttc agggctgccc agaatttgag gtccgatctt 1140 cgttcatatc aaggcttagt ccattcttat cttgcatttg gtaaaaccaa agaagcattg 1200 tataccgcca gggaagcaat gaatgcaatg cctcaatccg cgaaggctct gaaattagtt 1260 ggtgatgttc atgcgtttac atcaagtggc agggaaaagg caaaaaagtt ttacgagtca 1320 ggtctgaggc tggaacctgg gtaccttgga gctgtgttag ccctagctga gcttcatcta 1380 atggaaggga ggaatggaga tgctgtatca ctacttgaac gatatctcaa agattatgca 1440 gatgattctc tccacgtcaa gctagctcaa gtgtttgctg caacgaatat gctacaagat 1500 tctttatcac actttcaagc tgcattaaga sequencias ataaatccac ST25 agaatgaggc agccaaaaag 1560 ggactagatc gcttggagaa acaaatgaag ggaatagac cagatgcaac agatgagaat 1620 gacgagaacg atgttgaaga tgttgatgga gacaccgaag aagctgagct catgtgaaga 1680 gtagagagac agaagagtgt gtaaactgta aaactatcga atccttaaca ttaatattaa 1740 tagcaaatgt cattcct 1757 <210> 2 <211> 911 <212> DNA <213> Arabidopsis thaliana <400> 2 atggatgagt atgcgatgct gcttcagatt aagtgtgatt attccaggct aaacaagctc 60 gtccacgatt tattaagcgt tgatcatacc agagcagaag tatttgttgc tttgtctgta 120 ctatgggaaa ggaaagatgc aaggacggca ttatcttatg ctgagaagag tatcagggta 180 gacgagaggc acatacccgg ctacataatg aagggaaatc tacttttaca agcaaaacga 240 ccagaagctg cagcgatcgc cttcagggct gcccagaatt tgaggtccga tcttcgttca 300 tatcaaggct tagtccattc ttatcttgca tttggtaaaa ccaaagaagc attgtatacc 360 gccagggaag caatgaatgc aatgcctcaa tccgcgaagg ctctgaaatt agttggtgat 420 gttcatgcgt ttacatcaag tggcagggaa aaggcaaaaa agttttacga gtcaggtctg 480 aggctggaac ctgggtacct tggagctgtg ttagccctag ctgagcttca tctaatggaa 540 gggaggaatg gagatgctgt atcactactt gaacgatatc tcaaagatta tgcagatgat 600 tctctccacg tcaagctagc tcaagtgttt gctgcaacga atatgctaca agattcttta 660 tcacactttc aagctgcatt aagaataaat ccacagaatg aggcagccaa aaagggacta 720 gatcgcttgg agaaacaaat gaagggaata gacccagatg caacagatga gaatgacgag 780 aacgatgttg aagatgttga tggagacacc gaagaagctg agctcatgtg aagagtagag 840 agacagaaga gtgtgtaaac tgtaaaacta tcgaatcctt aacattaata ttaatagcaa 900 atgtcattcc t 911atggaggttc caaaggagca gatcgcgact ttaatagagc atgggcttta cgattctgct 60 gaaatgctcg gctgctttct cgtttcttct cctactgtta gtgccgaaac tagtcctcag 120 ctcaaggcgg agaatttgat tctactgggt gatgctttat ttcatcagag agaacaccgg 180 agagctattc atacgtacaa gcaagcgttg catcattaca caaggattcc gaagcaaagc 240 tccggtattt cgaggagttc attatcttta tctaccagat catctgtgaa tgcctccagc 300 atttctgcta ttaatgagaa cgaggtgaga ttcaagattg cttcatctca ctttgctctt 360 aatgaaacaa aagctgcgat tgctgagatg gaatctgtca agaccaggag cttagagatg 420 aatatactga tggcaaagct tcatcgaaat tctggataca accgtggtgc tattgctttt 480 tataaagagt gtttaaggca gtgtccttat gtacttgaag ccgtcatagg tttagctgaa 540 ctgggagtta gtgcaaagga tatcatatca tcgtttactc agacttcaaa tagaagtgca 600 aaggtttcac tcgatcagat agatcctacc cgctggttgc aacgttatgt agaggcccag 660 tgttgtgttg cttcgcatgc ttacaaaggg gcgctggaac tctttgctga actcttacaa 720 cgatttccaa ataatgtaca cttgttgact gagacagcaa aggttgaagc cattattggg 780 aaaaatgatg aggccataat gagatttgag aaggttcggt caattgatcc ttacacacta 840 accagtatgg atgagtatgc gatgctgctt cagattaagt gtgattattc caggctaaac 900 aagctcgtcc acgatttatt aagcgttgat cataccagag cagaagtatt tgttgctttg 960 tctgtactat gggaaaggaa agatgcaagg acggcattat cttatgctga gaagagtatc 1020 agggtagacg agaggcacat acccggctac ataatgaagg gaaatctact tttacaagca 1080 aaacgaccag aagctgcagc gatcgccttc agggctgccc agaatttgag gtccgatctt 1140 cgttcatatc aaggcttagt ccattcttat cttgcatttg gtaaaaccaa agaagcattg 1200 tataccgcca gggaagcaat gaatgcaatg cctcaatccg cgaaggctct gaaattagtt 1260 ggtgatgttc atgcgtttac atcaagtggc agggaaaagg caaaaaagtt ttacgagtca 1320 ggtctgaggc tggaacctgg gtaccttgga gctgtgttag ccctagctga gcttcatcta 1380 atggaaggga ggaatggaga tgctgtatca ctacttgaac gatatctcaa agattatgca 1440 gatgattctc tccacgtcaa gctagctcaa gtgtttgctg caacgaatat gctacaagat 1500 tctttatcac actttcaagc tgcattaaga sequences ataaatccac ST25 agaatgaggc agccaaaaag 1560 ggactagatc gcttggagaa acaaatgaag ggaatagac cagatgcaac agatgagaat 1620 gacgagaacg atgttgaaga tgttgatgga gacaccgaag aagctgagct catgtgaaga 1680 gtagagaga c agaagagtgt gtaaactgta aaactatcga atccttaaca ttaatattaa 1740 tagcaaatgt cattcct 1757 <210> 2 <211> 911 <212> DNA <213> Arabidopsis thaliana <400> 2 atggatgagt atgcgatgct gcttcagatt aagtgtgatt attccaggct aaacaagctc 60 gtccacgatt tattaagcgt tgatcatacc agagcagaag tatttgttgc tttgtctgta 120 ctatgggaaa ggaaagatgc aaggacggca ttatcttatg ctgagaagag tatcagggta 180 gacgagaggc acatacccgg ctacataatg aagggaaatc tacttttaca agcaaaacga 240 ccagaagctg cagcgatcgc cttcagggct gcccagaatt tgaggtccga tcttcgttca 300 tatcaaggct tagtccattc ttatcttgca tttggtaaaa ccaaagaagc attgtatacc 360 gccagggaag caatgaatgc aatgcctcaa tccgcgaagg ctctgaaatt agttggtgat 420 gttcatgcgt ttacatcaag tggcagggaa aaggcaaaaa agttttacga gtcaggtctg 480 aggctggaac ctgggtacct tggagctgtg ttagccctag ctgagcttca tctaatggaa 540 gggaggaatg gagatgctgt atcactactt gaacgatatc tcaaagatta tgcagatgat 600 tctctccacg tcaagctagc tcaagtgttt gctgcaacga atatgctaca agattcttta 660 tcacactttc aagctgcatt aagaataaat ccacagaatg aggcagccaa aaagggacta 720 g atcgcttgg agaaacaaat gaagggaata gacccagatg caacagatga gaatgacgag 780 aacgatgttg aagatgttga tggagacacc gaagaagctg agctcatgtg 840 agacagaaga gtgtgtaaac tggaaccta 900t
SEQUENCE LISTINGSEQUENCE LISTING
<110> UNIVERSIDADE FEDERAL DO RIO DE JANEIRO<110> RIO DE JANEIRO FEDERAL UNIVERSITY
<120> MÉTODO DE PROMOÇÃO DO AUMENTO EXACERBADO DA BIOMASSA VEGETAL <13O> Crescimento Vegetal <160> 2<120> METHOD FOR PROMOTING EXACERATED VEGETABLE BIOMASS INCREASE <13O> Plant Growth <160> 2
<170> PatentIn version 3.5<170> PatentIn version 3.5
<210> 1 <211> 1757 <212 > DNA<210> 1 <211> 1757 <212> DNA
<213> Arabidopsis thaliana <400> 1<213> Arabidopsis thaliana <400> 1
atggaggttc caaaggagca gatcgcgact ttaatagagc atgggcttta cgattctgctatggaggttc caaaggagca gatcgcgact ttaatagagc atgggcttta cgattctgct
6060
gaaatgctcg gctgctttct cgtttcttct cctactgtta gtgccgaaac tagtcctcag 120gaaatgctcg gctgctttct cgtttcttct cctactgtta gtgccgaaac tagtcctcag 120
ctcaaggcgg agaatttgat tctactgggt gatgctttat ttcatcagag agaacaccgg 180ctcaaggcgg agaatttgat tctactgggt gatgctttat ttcatcagag agaacaccgg 180
agagctattc atacgtacaa gcaagcgttg catcattaca caaggattcc gaagcaaagc 240agagctattc atacgtacaa gcaagcgttg catcattaca caaggattcc gaagcaaagc 240
tccggtattt cgaggagttc attatcttta tctaccagat catctgtgaa tgcctccagc 300tccggtattt cgaggagttc attatcttta tctaccagat catctgtgaa tgcctccagc 300
atttctgcta ttaatgagaa cgaggtgaga ttcaagattg cttcatctca ctttgctctt 360atttctgcta ttaatgagaa cgaggtgaga ttcaagattg cttcatctca ctttgctctt 360
aatgaaacaa aagctgcgat tgctgagatg gaatctgtca agaccaggag cttagagatg 420aatgaaacaa aagctgcgat tgctgagatg gaatctgtca agaccaggag cttagagatg 420
aatatactga tggcaaagct tcatcgaaat tctggataca accgtggtgc tattgctttt 480aatatactga tggcaaagct tcatcgaaat tctggataca accgtggtgc tattgctttt 480
tataaagagt gtttaaggca gtgtccttat gtacttgaag ccgtcatagg tttagctgaa 540tataaagagt gtttaaggca gtgtccttat gtacttgaag ccgtcatagg tttagctgaa 540
ctgggagtta gtgcaaagga tatcatatca tcgtttactc agacttcaaa tagaagtgca 600ctgggagtta gtgcaaagga tatcatatca tcgtttactc agacttcaaa tagaagtgca 600
aaggtttcac tcgatcagat agatcctacc cgctggttgc aacgttatgt agaggcccag 660aaggtttcac tcgatcagat agatcctacc cgctggttgc aacgttatgt agaggcccag 660
tgttgtgttg cttcgcatgc ttacaaaggg gcgctggaac tctttgctga actcttacaa 720 cgatttccaa ataatgtaca cttgttgact gagacagcaa aggttgaagc cattattggg aaaaatgatg aggccataat gagatttgag aaggttcggt caattgatcc ttacacacta accagtatgg atgagtatgc gatgctgctt cagattaagt gtgattattc caggctaaactgttgtgttg cttcgcatgc ttacaaaggg gcgctggaac tctttgctga actcttacaa 720 cgatttccaa ataatgtaca cttgttgact gagacagcaa aggttgaagc cattattggg aaaaatgatg aggccataat gagatttgag aaggttcggt caattgatcc ttacacacta accagtatgg atgagtatgc gatgctgctt cagattaagt gtgattattc caggctaaac
780780
840840
900 aagctcgtcc acgatttatt aagcgttgat cataccagag cagaagtatt tgttgctttg 960900 aagctcgtcc acgatttatt aagcgttgat cataccagag cagaagtatt tgttgctttg 960
tctgtactat gggaaaggaa agatgcaagg acggcattat cttatgctga gaagagtatc 1020tctgtactat gggaaaggaa agatgcaagg acggcattat cttatgctga gaagagtatc 1020
agggtagacg agaggcacat acccggctac ataatgaagg gaaatctact tttacaagca 1080agggtagacg agaggcacat acccggctac ataatgaagg gaaatctact tttacaagca 1080
aaacgaccag aagctgcagc gatcgccttc agggctgccc agaatttgag gtccgatctt 1140aaacgaccag aagctgcagc gatcgccttc agggctgccc agaatttgag gtccgatctt 1140
cgttcatatc aaggcttagt ccattcttat cttgcatttg gtaaaaccaa agaagcattg 1200cgttcatatc aaggcttagt ccattcttat cttgcatttg gtaaaaccaa agaagcattg 1200
tataccgcca gggaagcaat gaatgcaatg cctcaatccg cgaaggctct gaaattagtt 1260tataccgcca gggaagcaat gaatgcaatg cctcaatccg cgaaggctct gaaattagtt 1260
ggtgatgttc atgcgtttac atcaagtggc agggaaaagg caaaaaagtt ttacgagtca 1320ggtgatgttc atgcgtttac atcaagtggc agggaaaagg caaaaaagtt ttacgagtca 1320
ggtctgaggc tggaacctgg gtaccttgga gctgtgttag ccctagctga gcttcatcta 1380ggtctgaggc tggaacctgg gtaccttgga gctgtgttag ccctagctga gcttcatcta 1380
atggaaggga ggaatggaga tgctgtatca ctacttgaac gatatctcaa agattatgca 1440atggaaggga ggaatggaga tgctgtatca ctacttgaac gatatctcaa agattatgca 1440
gatgattctc tccacgtcaa gctagctcaa gtgtttgctg caacgaatat gctacaagat 1500gatgattctc tccacgtcaa gctagctcaa gtgtttgctg caacgaatat gctacaagat 1500
tctttatcac actttcaagc tgcattaaga ataaatccac agaatgaggc agccaaaaag 1560tctttatcac actttcaagc tgcattaaga ataaatccac agaatgaggc agccaaaaag 1560
ggactagatc gcttggagaa acaaatgaag ggaatagacc cagatgcaac agatgagaat 1620ggactagatc gcttggagaa acaaatgaag ggaatagacc cagatgcaac agatgagaat 1620
gacgagaacg atgttgaaga tgttgatgga gacaccgaag aagctgagct catgtgaaga 1680gacgagaacg atgttgaaga tgttgatgga gacaccgaag aagctgagct catgtgaaga 1680
gtagagagac agaagagtgt gtaaactgta aaactatcga atccttaaca ttaatattaa 1740gtagagagac agaagagtgt gtaaactgta aaactatcga atccttaaca ttaatattaa 1740
tagcaaatgt cattcct 1757tagcaaatgt cattcct 1757
<210> 2<210> 2
<211> 911<211> 911
<212> DNA<212> DNA
<213> Arabidopsis thaliana<213> Arabidopsis thaliana
<400> 2<400> 2
atggatgagt atgcgatgct gcttcagatt aagtgtgatt attccaggct aaacaagctcatggatgagt atgcgatgct gcttcagatt aagtgtgatt attccaggct aaacaagctc
6060
120120
gtccacgatt tattaagcgt tgatcatacc agagcagaag tatttgttgc tttgtctgtagtccacgatt tattaagcgt tgatcatacc agagcagaag tatttgttgc tttgtctgta
ctatgggaaa ggaaagatgc aaggacggca ttatcttatg ctgagaagag tatcagggta 180ctatgggaaa ggaaagatgc aaggacggca ttatcttatg ctgagaagag tatcagggta 180
gacgagaggc acatacccgg ctacataatg aagggaaatc tacttttaca agcaaaacga 240gacgagaggc acatacccgg ctacataatg aagggaaatc tacttttaca agcaaaacga 240
ccagaagctg cagcgatcgc cttcagggct gcccagaatt tgaggtccga tcttcgttca 300 tatcaaggct tagtccattc ttatcttgca tttggtaaaa ccaaagaagc attgtatacc 360ccagaagctg cagcgatcgc cttcagggct gcccagaatt tgaggtccga tcttcgttca 300 tatcaaggct tagtccattc ttatcttgca tttggtaaaa ccaaagaagc attgtatacc 360
gccagggaag caatgaatgc aatgcctcaa tccgcgaagg ctctgaaatt agttggtgat 420gccagggaag caatgaatgc aatgcctcaa tccgcgaagg ctctgaaatt agttggtgat 420
gttcatgcgt ttacatcaag tggcagggaa aaggcaaaaa agttttacga gtcaggtctg 480gttcatgcgt ttacatcaag tggcagggaa aaggcaaaaa agttttacga gtcaggtctg 480
aggctggaac ctgggtacct tggagctgtg ttagccctag ctgagcttca tctaatggaa 540aggctggaac ctgggtacct tggagctgtg ttagccctag ctgagcttca tctaatggaa 540
gggaggaatg gagatgctgt atcactactt gaacgatatc tcaaagatta tgcagatgat 600gggaggaatg gagatgctgt atcactactt gaacgatatc tcaaagatta tgcagatgat 600
tctctccacg tcaagctagc tcaagtgttt gctgcaacga atatgctaca agattcttta 660tctctccacg tcaagctagc tcaagtgttt gctgcaacga atatgctaca agattcttta 660
tcacactttc aagctgcatt aagaataaat ccacagaatg aggcagccaa aaagggacta 720tcacactttc aagctgcatt aagaataaat ccacagaatg aggcagccaa aaagggacta 720
gatcgcttgg agaaacaaat gaagggaata gacccagatg caacagatga gaatgacgag 780gatcgcttgg agaaacaaat gaagggaata gacccagatg caacagatga gaatgacgag 780
aacgatgttg aagatgttga tggagacacc gaagaagctg agctcatgtg aagagtagag 840aacgatgttg aagatgttga tggagacacc gaagaagctg agctcatgtg aagagtagag 840
agacagaaga gtgtgtaaac tgtaaaacta tcgaatcctt aacattaata ttaatagcaa 900agacagaaga gtgtgtaaac tgtaaaacta tcgaatcctt aacattaata ttaatagcaa 900
atgtcattcc t 911atgtcattcc t 911
Claims (20)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1009936-0A BRPI1009936A2 (en) | 2010-04-22 | 2010-04-22 | method of promoting the exacerbated increase in plant biomass |
| PCT/BR2011/000119 WO2011130815A2 (en) | 2010-04-22 | 2011-04-25 | Method for promoting an exacerbated increase in vegetable biomass |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI1009936-0A BRPI1009936A2 (en) | 2010-04-22 | 2010-04-22 | method of promoting the exacerbated increase in plant biomass |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1009936A2 true BRPI1009936A2 (en) | 2012-09-04 |
Family
ID=46508215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009936-0A BRPI1009936A2 (en) | 2010-04-22 | 2010-04-22 | method of promoting the exacerbated increase in plant biomass |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BRPI1009936A2 (en) |
| WO (1) | WO2011130815A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11525143B2 (en) | 2014-02-28 | 2022-12-13 | Universidade Federal Do Rio De Janeiro | Method for promoting an increase in plant biomass, productivity, and drought resistance |
| BR102014004881A2 (en) | 2014-02-28 | 2016-02-02 | Univ Rio De Janeiro | method to promote increased biomass and plant yield and drought tolerance |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2420555C (en) * | 2000-08-24 | 2012-10-23 | Jeffrey F. Harper | Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| EP1334121B1 (en) * | 2000-11-13 | 2013-03-13 | Universiteit Utrecht | A plant development regulating gene and its uses |
| WO2004016775A2 (en) * | 2002-08-14 | 2004-02-26 | Cropdesign N.V. | Plants having modified growth and a method for making the same |
| EP2090662A3 (en) * | 2006-04-05 | 2012-10-31 | Metanomics GmbH | Process for the production of a fine chemical |
| US20110307974A1 (en) * | 2008-12-05 | 2011-12-15 | Gerrit Beemster | Plant growth promoting protein complex |
-
2010
- 2010-04-22 BR BRPI1009936-0A patent/BRPI1009936A2/en not_active Application Discontinuation
-
2011
- 2011-04-25 WO PCT/BR2011/000119 patent/WO2011130815A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011130815A2 (en) | 2011-10-27 |
| WO2011130815A3 (en) | 2012-05-10 |
| WO2011130815A8 (en) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | ERF 109 of trifoliate orange (Poncirus trifoliata (L.) Raf.) contributes to cold tolerance by directly regulating expression of Prx1 involved in antioxidative process | |
| Jia et al. | Small tandem target mimic-mediated blockage of microRNA858 induces anthocyanin accumulation in tomato | |
| Pacak et al. | Investigations of barley stripe mosaic virus as a gene silencing vector in barley roots and in Brachypodium distachyon and oat | |
| Xiao et al. | An efficient virus-induced gene silencing (VIGS) system for functional genomics in Brassicas using a cabbage leaf curl virus (CaLCuV)-based vector | |
| Figueroa-Yanez et al. | RAP2. 4a is transported through the phloem to regulate cold and heat tolerance in papaya tree (Carica papaya cv. Maradol): implications for protection against abiotic stress | |
| US9725733B2 (en) | Polynucleotide encoding NF-YB derived from jatropha and use thereof | |
| BR112020008016A2 (en) | resistance to housing in plants | |
| Xiu et al. | Improvement and transcriptome analysis of root architecture by overexpression of Fraxinus pennsylvanica DREB2A transcription factor in Robinia pseudoacacia L.‘Idaho’ | |
| CN106244606B (en) | The new application of tomato s-nitrosoglutathione reductase gene | |
| JP2024513588A (en) | Mobile endonucleases for inherited mutations | |
| JP2016533179A (en) | Corn regulatory elements and uses thereof | |
| BRPI1009936A2 (en) | method of promoting the exacerbated increase in plant biomass | |
| KR102744700B1 (en) | OsPUB7 gene from Oryza sativa for controlling drought stress tolerance of plant and uses thereof | |
| JP2025535075A (en) | uORF::reporter gene ligation for selecting sequence changes for gene editing in uORFs to regulate expression of ascorbic acid genes | |
| CN117947087A (en) | Protein ZmLHP1 for regulating and controlling corn plant height and responding to high temperature stress and application thereof | |
| BR102014024813A2 (en) | metallothionein-type regulatory elements of zea mays and their uses | |
| BR112020026543A2 (en) | METHODS TO INCREASE THE REASON OF A PROTEIN, TO INCREASE THERMOTOLERANCE, INCREASE YIELD, TO PRODUCE A PLANT, TO INCREASE THERMOSTASTABILITY AND TO PRODUCE A PROTEIN VARIANT, PROTEIN VARIANT, NUCLEAR, NUCLEAR, NUCLEAR, NUCLEAR, NUCLEAR NUCLEAR AND THERMOSTABLE, PLANT, PART OF PLANT OR SEED, USE OF PROTEIN VARIANT, METHOD OF PRODUCTION OF FOOD AND CEREAL PLANT | |
| Bing et al. | Overexpression of the AtSTK gene increases salt, PEG and ABA tolerance in Arabidopsis | |
| CN105695462B (en) | Soybean MicroRNA172 is cultivating the application in plant with adverse resistance | |
| CN116179574A (en) | Application of CmEAF7 Gene in Improving Melon Cold Tolerance and/or Fruit Quality | |
| Jiang et al. | Efficient gene editing and overexpression of gametophyte transformation in a model fern | |
| KR102555522B1 (en) | CaGIR1 gene and Method for improving the resistance to the drought stress using CaGIR1 in plants | |
| CN120536490B (en) | Application of PpSec61γ in regulating chlorophyll degradation in plants | |
| KR102555526B1 (en) | CaFIRF1 genes and Method for improving the resistance to the drought and salt stress using CaFIRF1 in plants | |
| KR102841722B1 (en) | UP gene from Arabidopsis thaliana regulating resistance to environment stress in plant and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B12B | Appeal: appeal against refusal |